Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Ischemic Heart Disease

  Free Subscription


Articles published in Int J Cardiol

Retrieve available abstracts of 430 articles:
HTML format



Single Articles


    October 2026
  1. EMORI H, Shiono Y, Yamanobe H, Kawai S, et al
    Incidence of periprocedural myocardial injury and clinical outcomes after rotational atherectomy vs. intravascular lithotripsy.
    Int J Cardiol. 2026;460:134630.
    PubMed     Abstract available


  2. VADALA G, Mashayekhi K, Madaudo C, Behnes M, et al
    Patient profiles and outcomes of chronic total occlusion percutaneous revascularisation in middle- and high-income regions a cross-sectional study from the European Registry of Chronic Total Occlusions (ERCTO).
    Int J Cardiol. 2026;460:134625.
    PubMed     Abstract available


  3. DEHARO P, Gariboldi V, Marlinge M, Aliouane S, et al
    cAMP production secondary to A(2A) adenosine receptor activation as a biomarker of ischemia-reperfusion process: A comparative pilot study between CABG and PCI.
    Int J Cardiol. 2026;460:134612.
    PubMed     Abstract available


  4. CAPRANZANO P, Calabro P, Musumeci G, Di Mario C, et al
    Use of cangrelor in patients with reduced renal function: Post-hoc analysis from the ARCANGELO study.
    Int J Cardiol. 2026;460:134601.
    PubMed     Abstract available


    September 2026
  5. VICHOS T, Strepkos D, Alexandrou M, Carvalho PEP, et al
    Temporal trends in retrograde crossing of epicardial collaterals in chronic total occlusion percutaneous coronary intervention.
    Int J Cardiol. 2026;459:134586.
    PubMed     Abstract available


  6. TERINGOVA E, Molnar R, Saal B, Soosova I, et al
    Transforming post-STEMI care: The IMPACS study design and baseline patient profile.
    Int J Cardiol. 2026;459:134573.
    PubMed     Abstract available


  7. CAMILLERI W, Ntantou E, Kloosterman AV, Daemen J, et al
    Ostial vs proximal stenting in LAD stenosis: A comparative study.
    Int J Cardiol. 2026;459:134575.
    PubMed     Abstract available


    August 2026
  8. ISHII Y, Watabe H, Usami K, Terauchi T, et al
    Association between coronary high-intensity plaque and pericoronary adipose tissue attenuation and plaque morphology.
    Int J Cardiol. 2026;457:134552.
    PubMed     Abstract available


  9. ALARFAJ M, Mohamad Alahmad MA, Wallisch WJ, Flynn BC, et al
    ELSO-score: A practical pre-ECMO risk model for predicting in-hospital mortality in patients receiving VA-ECMO.
    Int J Cardiol. 2026;457:134542.
    PubMed     Abstract available


  10. PESCE F, Dini CS, Righini FM, Stefanini A, et al
    Optimizing cardiogenic shock outcomes: A system-based network approach.
    Int J Cardiol. 2026;457:134535.
    PubMed     Abstract available


  11. GADELMAWLA AF, Taha AM, Alkuwaiti FA, Alkuwaiti MA, et al
    Prognostic impact of persistent microvascular obstruction on cardiac magnetic resonance after STEMI: A systematic review and meta-analysis.
    Int J Cardiol. 2026;456:134523.
    PubMed     Abstract available


  12. KROLL C, Hubert A, Saccardi L, Martinez Pereyra V, et al
    (Long-term) efficacy of endotype-based drug therapy on quality of life and symptom management in coronary vasomotion disorders.
    Int J Cardiol. 2026;456:134518.
    PubMed     Abstract available


  13. GIOVACHINI L, Ferrante A, Guedeney P, Rahoual G, et al
    Impacts of stent characteristics on periprocedural ischemic events in elective PCI: the ALPHEUS-stents study.
    Int J Cardiol. 2026;456:134506.
    PubMed     Abstract available


    July 2026
  14. WU JY, Lee KW, Huang SC, Chang HY, et al
    Association between Ranolazine use and outcomes in patients with suspected MINOCA: A propensity-matched cohort study.
    Int J Cardiol. 2026;455:134504.
    PubMed     Abstract available


  15. FREENE N, Seymour J, McPhail SM, Tyack Z, et al
    Frequency of a very brief intervention to increase physical activity levels in cardiac rehabilitation attendees: The 'Measure It!' Multicentre randomised trial.
    Int J Cardiol. 2026;455:134480.
    PubMed     Abstract available


  16. NGUYEN KD, Vu VH, Duong BT, Tran H, et al
    Percutaneous coronary intervention registries in the Asia-Pacific region: A systematic review of methodology and patient characteristics and meta-analysis of in-hospital mortality rate.
    Int J Cardiol. 2026;454:134453.
    PubMed     Abstract available


  17. JIANG T, Chen C, Shao M, Ma J, et al
    The inflammation-microvascular axis in prognosis: Integrated FAI and AMR assessment for risk stratification after PCI in NSTEMI patients.
    Int J Cardiol. 2026;454:134455.
    PubMed     Abstract available


  18. LIU J, Lyu Q, Li J, He X, et al
    Low-dose telmisartan protects against myocardial ischemia/reperfusion injury via dual mechanisms: AMPK activation and AMPK-independent calcium homeostasis.
    Int J Cardiol. 2026;454:134450.
    PubMed     Abstract available


  19. AMBROSIO G, Gowdak LHW, Weiskopf RB, Zieroth S, et al
    Applicability of ischemic heart disease clinical practice guidelines in low- and middle-income countries.
    Int J Cardiol. 2026 Jul 1:134637. doi: 10.1016/j.ijcard.2026.134637.
    PubMed     Abstract available


    June 2026
  20. SONAGLIONI A, Nicolosi GL
    Beyond pre-test probability: Refining chronic coronary disease risk stratification through chest wall conformation and stress echocardiography.
    Int J Cardiol. 2026 Jun 24:134639. doi: 10.1016/j.ijcard.2026.134639.
    PubMed    


  21. LENSELINK C, Lau YH, Huang W, Ewe SH, et al
    Clinical and artificial intelligence assessed echocardiographic predictors of outcomes after acute myocardial infarction.
    Int J Cardiol. 2026;460:134638.
    PubMed     Abstract available


  22. CUI L, Zhao J, Gao Y, Chen Y, et al
    Plaque characteristics and clinical outcomes of non-culprit long lesions in patients with acute myocardial infarction.
    Int J Cardiol. 2026 Jun 17:134627. doi: 10.1016/j.ijcard.2026.134627.
    PubMed     Abstract available


  23. ANGIOLILLO DJ, Erlinge D, Gale CP, Gorog DA, et al
    Real-world adoption of the 2023 European Society of Cardiology guidelines regarding antiplatelet strategies in acute coronary syndromes: Insights from the European READAPT-2 survey.
    Int J Cardiol. 2026;453:134288.
    PubMed     Abstract available


  24. KANG DO, Kim W, van Assen M, De Cecco CN, et al
    Drug-coated balloon versus drug-eluting stent for isolated ostial side-branch bifurcation (Medina 0.0.1) lesions.
    Int J Cardiol. 2026;460:134621.
    PubMed     Abstract available


  25. DI SERAFINO L, Ciaramella L, De Rosa S, Torella D, et al
    Inhibition of late sodium current (INa) to prevent coronary MICROvascular dysfunction in patients presenting with ST-elevation myocardial infarction and multivessel disease: A phase IIb multicenter, randomized, controlled and open label study (INaMICR
    Int J Cardiol. 2026 Jun 11:134620. doi: 10.1016/j.ijcard.2026.134620.
    PubMed     Abstract available


  26. YAMAMOTO MH, Mizukami T, Mori H, Kobayashi N, et al
    Impact of absolute stent expansion on two-year clinical outcomes after PCI in patients with acute coronary syndrome: Results from the OCT-guided PCI registry (TACTICS registry).
    Int J Cardiol. 2026;452:134263.
    PubMed     Abstract available


    May 2026
  27. ROBINSON K, Hung J, Wright FL, Katzenellenbogen JM, et al
    Characteristics, readmission patterns and trends in hospitalisations for chronic coronary disease in Western Australia, 2005 to 2022.
    Int J Cardiol. 2026 May 27:134589. doi: 10.1016/j.ijcard.2026.134589.
    PubMed     Abstract available


  28. GOPAL A, Kamrada C, Awad A, Chalhoub M, et al
    Association of Baseline SSRI use with post-STEMI outcomes in patients with depression.
    Int J Cardiol. 2026 May 26:134585. doi: 10.1016/j.ijcard.2026.134585.
    PubMed     Abstract available


  29. YOSOFI B, Zelis JM, Raafs A, Teeuwen K, et al
    Traditional left ventricular indices outperform novel cardiovascular magnetic resonance-derived left atrial parameters in predicting adverse left ventricular remodelling after ST-segment elevation myocardial infarction.
    Int J Cardiol. 2026;459:134587.
    PubMed     Abstract available


  30. BUTT H, van Beek K, Sajjad U, Ibrahim A, et al
    Pre-perfusion coronary wedge pressure and microvascular obstruction in anterior ST elevation myocardial infarction (STEMI): An analysis from the EUROICE study.
    Int J Cardiol. 2026;459:134558.
    PubMed     Abstract available


  31. SKI CF, Thompson DR, Jennings CS, Kotseva K, et al
    Female sex is independently associated with poor health-related quality of life in patients with coronary heart disease across 14 countries: the INTERASPIRE study.
    Int J Cardiol. 2026 May 20:134563. doi: 10.1016/j.ijcard.2026.134563.
    PubMed     Abstract available


  32. KUBIK S
    Prognostic significance of provocation spasm testing in patients with myocardial infarction with and without obstructive coronary arteries.
    Int J Cardiol. 2026 May 20:134572. doi: 10.1016/j.ijcard.2026.134572.
    PubMed    


  33. CHENG A, Wu Y, Mou F, Zhou J, et al
    Drug-coated balloon versus drug-eluting stent for treating de novo proximal left anterior descending artery lesions: Insights from the REC-CAGEFREE I trial.
    Int J Cardiol. 2026;451:134267.
    PubMed     Abstract available


  34. GHETTI G, Taglieri N, Guiducci V, Capecchi A, et al
    Bail-out stenting and target-vessel failure after drug-coated balloon percutaneous coronary angioplasty for de novo lesions: The BOSS study.
    Int J Cardiol. 2026;451:134250.
    PubMed     Abstract available


  35. LOMBARDI M, Chiabrando JG, Occhipinti G, Elia E, et al
    Long term outcomes of different revascularization strategies in left main coronary artery: a network meta-analysis.
    Int J Cardiol. 2026;457:134539.
    PubMed     Abstract available


  36. HUA M, Liang R, Nie W, Zhou L, et al
    Novel insights into myocardial synchrony: A CMR-based approach for improving the detection of coronary artery disease at rest.
    Int J Cardiol. 2026;450:134221.
    PubMed     Abstract available


  37. PRATI F, Biccire FG, Mallus MT, Mastroianni F, et al
    Coronary inflammation: Identification, clinical impact and possible therapeutical solutions.
    Int J Cardiol. 2026;450:134229.
    PubMed     Abstract available


  38. CAI ML, Shi WX, Li J, Li T, et al
    Phase III cardiac rehabilitation improves left ventricular ejection fraction in patients with coronary artery disease and mildly reduced ejection fraction after percutaneous coronary intervention.
    Int J Cardiol. 2026;450:134219.
    PubMed     Abstract available


  39. CHIOTIS S, Giannopoulos G, Boulmpou A, Zgouridou A, et al
    Association of common risk factors with major adverse cardiac events and mortality in patients with MINOCA: A systematic review and meta-analysis.
    Int J Cardiol. 2026;450:134225.
    PubMed     Abstract available


  40. WOUDSTRA J, Dimitriu-Leen AC, Crooijmans C, Yosofi B, et al
    Microvascular vasomotor dysfunction is more prevalent in female versus epicardial vasomotor dysfunction in male ANOCA patients.
    Int J Cardiol. 2026;450:134226.
    PubMed     Abstract available


    April 2026
  41. DEL TORTO A, Ventura E, Cannata F, Celeste F, et al
    Cardiac magnetic resonance in acute myocardial infarction undergoing thrombus aspiration.
    Int J Cardiol. 2026 Apr 30:134537. doi: 10.1016/j.ijcard.2026.134537.
    PubMed     Abstract available


  42. POLLER A, Jha S, Thorleifsson SJ, Espinosa AS, et al
    Left ventricular diastolic function over the acute and subacute phase in the Takotsubo syndrome versus ST-elevation myocardial infarction.
    Int J Cardiol. 2026;456:134522.
    PubMed     Abstract available


  43. AYAYO SA, Mamas MA
    Evolving epidemiology and improving outcomes in acute myocardial infarction: Lessons from 25 years of population-level data.
    Int J Cardiol. 2026;456:134511.
    PubMed    


  44. BO K, Qu T, Wang H, Yue X, et al
    Deep learning-based non-contrast cine CMR for optimized prediction of left ventricular adverse remodeling after ST-elevation myocardial infarction.
    Int J Cardiol. 2026 Apr 22:134499. doi: 10.1016/j.ijcard.2026.134499.
    PubMed     Abstract available


  45. YUAN W, Guo Y, Xu R
    Editorial to "Radiomics with native T1 mapping for contrast-free detection of acute and chronic myocardial infarction: A multicenter study".
    Int J Cardiol. 2026 Apr 20:134501. doi: 10.1016/j.ijcard.2026.134501.
    PubMed    


  46. LARA-GONZALEZ M, Munoz P, Pedraz-Prieto A, Delgado-Montero A, et al
    Prognostic impact of previous and new myocardial infarction in patients with infective endocarditis.
    Int J Cardiol. 2026;456:134508.
    PubMed     Abstract available


  47. LOU Q, Bai R, Li L, Lu B, et al
    Targeting ADAMTS4 aggravates myocardial ischemia-reperfusion injury by impairing endothelial integrity and accelerating leukocyte infiltration.
    Int J Cardiol. 2026;449:134195.
    PubMed     Abstract available


  48. FEZZI S, Zhu Y, Bargary N, Ding D, et al
    Predicting functional results of percutaneous coronary intervention using machine learning modelling.
    Int J Cardiol. 2026;449:134183.
    PubMed     Abstract available


  49. JIN S, Liu W, Chen X, Guo W, et al
    Caveolin-3 serves as a therapeutic target for myocardial ischemia-reperfusion injury in cardiac surgery patients.
    Int J Cardiol. 2026;449:134179.
    PubMed     Abstract available


  50. ABUMAYYALEH M, Behnes M, Akin I, Schupp T, et al
    Is the obesity paradox overstated? The underrecognized role of inflammation in myocardial infarction.
    Int J Cardiol. 2026 Apr 10:134479. doi: 10.1016/j.ijcard.2026.134479.
    PubMed    


  51. DE Y, Han Y, Song Y, Zhang X, et al
    Joint effects of pulse pressure and LVEF on 12-month mortality in acute coronary syndrome patients undergoing PCI.
    Int J Cardiol. 2026;448:134174.
    PubMed     Abstract available


  52. ROSENTHAL LM, Yavasca E, Miera O, Krauss A, et al
    Optical coherence tomography for early detection of cardiac allograft vasculopathy in pediatric heart recipients.
    Int J Cardiol. 2026;448:134146.
    PubMed     Abstract available


    March 2026
  53. PERAZA DELGADO AD, Edel PG, Rodriguez IM, Ferrer MF, et al
    Evolution of the risk of death during hospitalization for myocardial infarction in the regions of Spain between the periods 2007-2014 and 2018-2023.
    Int J Cardiol. 2026 Mar 18:134435. doi: 10.1016/j.ijcard.2026.134435.
    PubMed     Abstract available


  54. BILATO C, Girardi G, Zuin M, Salmaso L, et al
    Temporal trend in epidemiology and performance indicators of acute myocardial infarction: A 25 years population-based study.
    Int J Cardiol. 2026 Mar 18:134434. doi: 10.1016/j.ijcard.2026.134434.
    PubMed     Abstract available


  55. GUO Y, Song X, Xu T, Guo H, et al
    Utilizing machine learning in echocardiographic analysis to distinguish obstructive and non-obstructive coronary artery disease.
    Int J Cardiol. 2026;447:134121.
    PubMed     Abstract available


  56. HAKIM D, Ahmed M, Koo C, Coskun AU, et al
    Role of endothelial shear stress metrics in the development and eruption of coronary calcified nodules.
    Int J Cardiol. 2026;447:134117.
    PubMed     Abstract available


  57. COSENTINO N, Velato L, Bonomi A, Morocutti C, et al
    Severe obesity and in-hospital outcomes in acute myocardial infarction: Insights into the role of systemic inflammation.
    Int J Cardiol. 2026 Mar 10:134287. doi: 10.1016/j.ijcard.2026.134287.
    PubMed     Abstract available


  58. OZAWA T, Goto K, Hirokane A, Mizuno T, et al
    Prognostic significance of provocative spasm tests in patients with myocardial infarction with and without obstructive coronary arteries.
    Int J Cardiol. 2026;452:134277.
    PubMed     Abstract available


  59. SAKAI A, Nagao M, Yamamoto A, Nakao R, et al
    Prognostic value of (13)N-ammonia positron emission tomography-derived myocardial strain ratio in ischemia with non-obstructive coronary arteries.
    Int J Cardiol. 2026;446:134094.
    PubMed     Abstract available


  60. HOEK R, de Winter RW, Planken NR, Somsen YBO, et al
    Non-invasive hybrid functional and anatomical imaging for guiding revascularization decision-making by the heart team in patients with prior coronary artery bypass grafting.
    Int J Cardiol. 2026;446:134086.
    PubMed     Abstract available


  61. CHANDRA P, Sharma YP, Kapoor R, Singhal R, et al
    The TRANSEVER registry - A prospective, open-label, multicentre, post market surveillance study of ISAR SUMMIT polymer-free Everolimus eluting stent in a real-world Indian population of patients with coronary artery disease: One-year outcomes of the f
    Int J Cardiol. 2026;446:134067.
    PubMed     Abstract available


  62. MARZILLI M, Gowdak LHW, Sobhy M, Mittal S, et al
    Early combination therapy with trimetazidine rapidly improves symptoms and quality of life in patients recently diagnosed with stable angina: The COMBINE angina study.
    Int J Cardiol. 2026;446:134050.
    PubMed     Abstract available


    February 2026
  63. SANS-ROSELLO J, Fernandez-Peregrina E, Kuku KO, Torres-Ruiz G, et al
    Timing of cardiogenic shock and clinical outcomes in takotsubo syndrome: A multicenter cohort study.
    Int J Cardiol. 2026 Feb 27:134270. doi: 10.1016/j.ijcard.2026.134270.
    PubMed     Abstract available


  64. TAN C, Eaves S, Lo A, Mallouhi M, et al
    Diastolic dysfunction assessed by the 2025 American Society of Echocardiography guidelines and survival following myocardial infarction.
    Int J Cardiol. 2026;451:134246.
    PubMed     Abstract available


  65. LI S, Huo H, Zheng Y, Liu S, et al
    Radiomics with native T1 mapping for contrast-free detection of acute and chronic myocardial infarction: A multicenter study.
    Int J Cardiol. 2026 Feb 17:134222. doi: 10.1016/j.ijcard.2026.134222.
    PubMed     Abstract available


  66. HOTCHI Y, Tanaka R, Kojima Y, Shiozaki M, et al
    Validation of the 0/1-hour cardiac myosin-binding protein C algorithm and establishment of sex-specific reference limits in a Japanese population.
    Int J Cardiol. 2026;445:134082.
    PubMed     Abstract available


  67. SLEGERS DPJ, Bova R, Heuts SFM, Betti M, et al
    Diffuse coronary artery disease leads to deferral of both surgical and percutaneous coronary artery revascularisation.
    Int J Cardiol. 2026;445:134049.
    PubMed     Abstract available


  68. BRUCATO F, Tognola C, Moreo A, Bellomare M, et al
    Eligibility for Icosapent ethyl in patients undergoing cardiac rehabilitation: A real-world cohort study.
    Int J Cardiol. 2026;445:134046.
    PubMed     Abstract available


  69. DE VITA A, Marino AG, Cambise N, Lamendola P, et al
    Coronary microvascular dysfunction in patients with acute coronary syndrome and non-obstructive coronary artery disease: a 10-year clinical follow-up study.
    Int J Cardiol. 2026;445:134031.
    PubMed     Abstract available


  70. HADA M, Hoshino M, Watanabe T, Usui E, et al
    Determinants and prognostic significance of microvascular resistance reserve stratified by functional severity of epicardial stenosis.
    Int J Cardiol. 2026;445:134027.
    PubMed     Abstract available


  71. JAMAL J, Yang K, Ediriweera T, O'Loughlin A, et al
    Early and late outcomes of patients presenting with STEMI in the absence of standard modifiable risk factors: a reperfusion strategy aggregated analysis.
    Int J Cardiol. 2026;445:134008.
    PubMed     Abstract available


  72. LECHNER I, Reindl M, Metzler B, Reinstadler SJ, et al
    PCSK9 and residual risk after ST-elevation myocardial infarction.
    Int J Cardiol. 2026;450:134231.
    PubMed    


  73. MASCIA G, Cammarano M, Palmieri V, Monti R, et al
    Coronary CT angiography in master athletes: Redefining primary prevention of ischemic heart disease behind the Italian 2023 COCIS guidelines.
    Int J Cardiol. 2026 Feb 2:134214. doi: 10.1016/j.ijcard.2026.134214.
    PubMed     Abstract available


  74. CANEDO E, Carrillo-Suarez X, Fernandez-Nofrerias E, Rodriguez-Leor O, et al
    Association between activated clotting time and TIMI flow in STEMI patients pre-treated with unfractionated heparin.
    Int J Cardiol. 2026;444:134007.
    PubMed     Abstract available


  75. MOLNAR D, Knuuti J, Bax JJ, Saraste A, et al
    Sex differences in plaque burden and outcomes in symptomatic patients with suspected coronary artery disease.
    Int J Cardiol. 2026;444:134023.
    PubMed     Abstract available


  76. CHERBI M, Roubille F, Lamblin N, Puymirat E, et al
    Cardiogenic shock: Who benefits from heart replacement therapy?
    Int J Cardiol. 2026;444:134003.
    PubMed     Abstract available


  77. PEREA-ARMIJO J, Herrera-Flores J, Suarez de Lezo-Herreros de Tejada J, Hidalgo-Lesmes FJ, et al
    Inverted provisional in the left main: A therapeutic alternative in ostial circumflex lesions.
    Int J Cardiol. 2026;444:133994.
    PubMed     Abstract available


  78. BESUTTI M, Guillon B, Barthod C, Ecarnot F, et al
    Diagnostic yield of referring patients for invasive coronary angiography primarily based on high CAC scores: Positive predictive value for obstructive coronary artery disease in a consecutive real-life cohort.
    Int J Cardiol. 2026;444:133979.
    PubMed     Abstract available


    January 2026
  79. IKEDA A, Fukushima K, Ishii S, Endo K, et al
    Assessment of left ventricular mechanical synchrony and intraventricular blood flow energy in ischemic heart disease using a hybrid positron emission tomography-magnetic resonance system.
    Int J Cardiol. 2026;449:134200.
    PubMed     Abstract available


  80. SOUSA RB, Lima MR, Lopes PM, Freitas P, et al
    Impact of using the 2024 ESC guideline-recommended method to estimate the likelihood of obstructive coronary disease - a cardiac CT study.
    Int J Cardiol. 2026;449:134209.
    PubMed     Abstract available


  81. DING X, Dang W, Li W, Wang M, et al
    Impact of G protein-coupled receptor autoantibodies on clinical outcomes in patients with ST-segment elevation myocardial infarction.
    Int J Cardiol. 2026 Jan 18:134185. doi: 10.1016/j.ijcard.2026.134185.
    PubMed     Abstract available


  82. HAYEK A, Leboube S, Brun C, Moulin F, et al
    CSK9 is a predictive biomarker of major adverse events after acute myocardial infarction.
    Int J Cardiol. 2026 Jan 12:134176. doi: 10.1016/j.ijcard.2026.134176.
    PubMed     Abstract available


  83. GIACOBBE F, D'Ascenzo F
    Embracing heterogeneity after myocardial infarction: beyond STEMI and NSTEMI towards a personalized cardiovascular care.
    Int J Cardiol. 2026;448:134167.
    PubMed    


  84. CHIUSOLO S, Masini G, Zywicki V, Bort IR, et al
    High-intensity versus very-high-intensity statin, both on top of ezetimibe, in acute myocardial infarction: A pragmatic randomized study.
    Int J Cardiol. 2026;448:134140.
    PubMed     Abstract available


  85. COERKAMP CF, Hinderks MJ, Elias J, van Veelen A, et al
    Effect of percutaneous coronary intervention for chronic total occlusion on diastolic atrioventricular coupling in ST-elevation myocardial infarction patients.
    Int J Cardiol. 2026;448:134154.
    PubMed     Abstract available


  86. HONDA S, Noguchi T
    A step back in time, or a call to action? Revisiting cardiology-unit access in modern acute myocardial infarction treatment.
    Int J Cardiol. 2026 Jan 6:134144. doi: 10.1016/j.ijcard.2025.134144.
    PubMed    


  87. VON OSMANSKI BI, Ankarfeldt MZ, Olsen NT, Mouridsen MR, et al
    Ten clinically important subgroups of myocardial infarction survivors: Identification by latent class analysis.
    Int J Cardiol. 2026 Jan 6:134139. doi: 10.1016/j.ijcard.2025.134139.
    PubMed     Abstract available


  88. KHALED S, Tantawi W, Ahmed WE, Shaikh M, et al
    The impact of post discharge virtual cardiac remote monitoring for patients with acute coronary syndrome during HAJJ season 1445H- KAMC experience.
    Int J Cardiol. 2026;442:133900.
    PubMed     Abstract available


  89. SAMY M, Allali A, Alotaibi S, Toelg R, et al
    Serial quantitative flow ratio measurements of a successfully recanalized coronary chronic total occlusion.
    Int J Cardiol. 2026;442:133897.
    PubMed     Abstract available


  90. YANG X, Li B, Chen H, Ding R, et al
    CCTA-quantified pericornary inflammation and lipoprotein (a): Combined predictive value in non-obstructive CAD.
    Int J Cardiol. 2026;442:133887.
    PubMed     Abstract available


  91. MORENO R, Baptista SB, Rivero-Santana B, Valencia J, et al
    Benefit of coronary stenting using available intracoronary tools in high-risk patients. The OPTI-XIENCE study.
    Int J Cardiol. 2026;442:133847.
    PubMed     Abstract available


  92. AL QARAGHULI A, Chitturi KR, Kumar S, Cellamare M, et al
    Exploring the impact of age on microvascular function: Insights from the Coronary Microvascular Disease Registry.
    Int J Cardiol. 2026;442:133858.
    PubMed     Abstract available


  93. RUMIZ E, Rivero F, Perez A, Nau G, et al
    ESP-INOCA: Rationale and design of a national multicentre registry for prognostic stratification in patients with suspected myocardial ischaemia and non-obstructive coronary arteries.
    Int J Cardiol. 2026;442:133845.
    PubMed     Abstract available


  94. SHOJAZADEH A, Hadjiabdolhamid N, Lee C, Antunes IM, et al
    Early detection of coronary artery disease using low-dose CT perfusion: An experimental western fat diet study.
    Int J Cardiol. 2026;442:133793.
    PubMed     Abstract available


    December 2025
  95. CHEN X, Bao Y, Wang J
    Reinterpreting interleukin-1 receptor antagonist elevation in acute myocardial infarction.
    Int J Cardiol. 2025;441:133697.
    PubMed    


  96. ZHANG R, Jiang B, Zhao W, Liu J, et al
    A combined radiomics-clinical model for early detection of coronary plaque development in coronary CT angiography-negative populations.
    Int J Cardiol. 2025;441:133778.
    PubMed     Abstract available


  97. MASUDA Y, Takeshita R, Tsujimoto A, Sahashi Y, et al
    Automated coronary artery segmentation / tissue characterization and detection of lipid-rich plaque: An integrated backscatter intravascular ultrasound study.
    Int J Cardiol. 2025;441:133744.
    PubMed     Abstract available


  98. BENEDETTI A, Fusi C, Coeman M, Ghafari C, et al
    Deferred revascularization of left main stenosis based on instantaneous wave-free ratio: Long-term clinical outcomes from the PHYNAL registry.
    Int J Cardiol. 2025;441:133745.
    PubMed     Abstract available


  99. DILENA DD, Huang J, Rauchwerger AS, Reed ME, et al
    Identifying low-risk patients within the observation zone of a 0/2-h high-sensitivity troponin diagnostic protocol for chest pain evaluation.
    Int J Cardiol. 2025;440:133730.
    PubMed     Abstract available


  100. LI S, Bo K, Ma W, Li W, et al
    Impact of metabolic dysfunction-associated fatty liver disease on left ventricular function and myocardial strain in patients with ASTEMI: Insights from a 3.0-T cardiac magnetic resonance study.
    Int J Cardiol. 2025;440:133709.
    PubMed     Abstract available


  101. LIU C, Yang F, Hu Y, Wang L, et al
    Relationship between coronary artery calcification and plaque vulnerability, a qualitative and quantitative optical coherence tomography study.
    Int J Cardiol. 2025;440:133707.
    PubMed     Abstract available


  102. KOCH T, Tauchmann L, Cassese S, Xhepa E, et al
    Long-term safety and efficacy of rotational atherectomy for lesion preparation of calcified coronary lesions.
    Int J Cardiol. 2025;440:133711.
    PubMed     Abstract available


  103. RALLIDIS LS, Tsamoulis D, Papathanasiou KA, Kalogeras P, et al
    Eligibility for icosapent ethyl 1-3 months after acute coronary syndrome and the risk for myocardial re-infarction: Data from the CALLINICUS-Hellas Registry.
    Int J Cardiol. 2025;440:133684.
    PubMed     Abstract available


    November 2025
  104. DE LUCA L, Raone L, Rosato S, D'Errigo P, et al
    The prognostic role of cardiology management during index admission for acute myocardial infarction: A nationwide administrative dataset analysis.
    Int J Cardiol. 2025 Nov 28:134069. doi: 10.1016/j.ijcard.2025.134069.
    PubMed     Abstract available


  105. AHMAD O, Ibrahim R, Pham HN, Abdelnabi M, et al
    Early glucagon-like peptide-1 receptor agonist use after myocardial infarction in patients with type 2 diabetes.
    Int J Cardiol. 2025 Nov 24:134042. doi: 10.1016/j.ijcard.2025.134042.
    PubMed     Abstract available


  106. ZHANG W, Chen Y, Zhu L, Peng S, et al
    Prognostic value of the FIB-4 index in patients with myocardial infarction with non-obstructive coronary arteries.
    Int J Cardiol. 2025;445:134045.
    PubMed     Abstract available


  107. EGGERS KM, Hamilton E, Jernberg T, Lindahl B, et al
    Predictors of depressed left-ventricular ejection fraction after acute myocardial infarction.
    Int J Cardiol. 2025 Nov 24:134040. doi: 10.1016/j.ijcard.2025.134040.
    PubMed     Abstract available


  108. DAYAWANSA NH, Vogrin S, Zheng WC, Lefkovits J, et al
    Safety and performance of complex percutaneous coronary intervention in centres with and without on-site cardiac surgery: A multi-centre Australian study.
    Int J Cardiol. 2025 Nov 17:134032. doi: 10.1016/j.ijcard.2025.134032.
    PubMed     Abstract available


  109. GIACOBBE F, Bruno F, Giannino G, Angelini F, et al
    Safety and efficacy of P2Y12 inhibitors in acute coronary syndromes patients with KDIGO stage IV-V renal disfunction not on dialysis: a subanalysis of the CORALYS registry.
    Int J Cardiol. 2025;439:133613.
    PubMed     Abstract available


  110. TOGNOLA C, Bernasconi D, Intravaia RCM, Brioschi G, et al
    Prevalence of hypertriglyceridemia and its association with extreme cardiovascular risk in patients with acute and chronic coronary syndrome enrolled in a cardiac rehabilitation program.
    Int J Cardiol. 2025;439:133608.
    PubMed     Abstract available


  111. LI F, Zhang JJ, Ruan GJ, Zhan YY, et al
    Prediction models for no-reflow phenomenon after PCI in acute coronary syndrome patients: A systematic review.
    Int J Cardiol. 2025;439:133603.
    PubMed     Abstract available


  112. XU X, Liu Z, Liu Z, Li Z, et al
    Increased sympathetic outflow induced by ventromedial hypothalamic nucleus activation aggravates cardiac electrophysiology disturbance after myocardial ischemia-reperfusion injury.
    Int J Cardiol. 2025;439:133634.
    PubMed     Abstract available


  113. NOGAMI K, Ozcan I, Kanaji Y, Gulati R, et al
    Long-term temporal trend in plaque eccentricity assessed through intravascular ultrasound imaging after heart transplantation.
    Int J Cardiol. 2025;444:134022.
    PubMed     Abstract available


  114. GADAGER BB, Tang LH, Sevel C, Doherty P, et al
    Change in exercise capacity after cardiac rehabilitation following coronary heart disease in patients with and without diabetes: A follow-up study.
    Int J Cardiol. 2025;444:134005.
    PubMed     Abstract available


  115. PAPAZOGLOU AS, Tsiartas E, Kyriakoulis KG, Moysidis DV, et al
    Prevalence and clinical impact of baseline atherosclerotic vascular disease in patients undergoing transcatheter aortic valve implantation: A meta-analysis.
    Int J Cardiol. 2025;444:134004.
    PubMed     Abstract available


  116. KATO T, Suzuki K, Kawashima H, Kato Y, et al
    Changes in syndecan-1 concentration in the coronary sinus immediately after cardiac reperfusion reflect postoperative myocardial injury.
    Int J Cardiol. 2025;438:133564.
    PubMed     Abstract available


  117. NEBIOLO M, Kang J, Sandrone S, Kim HK, et al
    Duration of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention for bifurcation lesions: Insights from the ULTRA-BIFURCAT registry.
    Int J Cardiol. 2025;438:133542.
    PubMed     Abstract available


  118. HU C
    Cangrelor: A new P2Y12 inhibitor with gender differences.
    Int J Cardiol. 2025;438:133511.
    PubMed     Abstract available


    October 2025
  119. RACHWAN RJ, Chehab O, Bou Chaaya RG, Daher G, et al
    A simple clinical scoring model to predict significant left main/three-vessel disease in non-ST elevation acute coronary syndrome: The MADISON score.
    Int J Cardiol. 2025 Oct 26:133976. doi: 10.1016/j.ijcard.2025.133976.
    PubMed     Abstract available


  120. ELSCOT JJ, Kakar H, den Dekker WK, Bennett J, et al
    Immediate versus staged complete revascularization in patients presenting with multivessel disease and ST- or non-ST-segment elevation acute coronary syndrome.
    Int J Cardiol. 2025;437:133496.
    PubMed     Abstract available


  121. LIU Y, Fu X, Ai X, Li G, et al
    Carotid Intraplaque neovascularization correlates with coronary atherosclerotic plaque, vulnerability detected by intracoronary optical coherence tomography.
    Int J Cardiol. 2025;437:133495.
    PubMed     Abstract available


  122. NAMMAS W, Ajosenpaa I, Maaniitty T, Stenstrom I, et al
    Prognostic utility of hybrid coronary computed tomography angiography and myocardial perfusion imaging in elderly patients with suspected coronary artery disease.
    Int J Cardiol. 2025;437:133493.
    PubMed     Abstract available


  123. ZENG L, Hu F, Qin P, Jia T, et al
    Dual energy CT-based Radiomics for identification of myocardial focal scar and artificial beam-hardening.
    Int J Cardiol. 2025;437:133482.
    PubMed     Abstract available


  124. LU H, Zhang Y, Yang P, Zhao H, et al
    Novel high-burden thrombus criterion: Thrombectomy plus thrombolysis improves microvascular resistance in myocardial infarction.
    Int J Cardiol. 2025;443:133970.
    PubMed     Abstract available


  125. OLAWADE DB, Soladoye AA, Omodunbi BA, Aderinto N, et al
    Comparative analysis of machine learning models for coronary artery disease prediction with optimized feature selection.
    Int J Cardiol. 2025;436:133443.
    PubMed     Abstract available


    September 2025
  126. POLLER A, Bech-Hanssen O, Redfors B
    Reply to "On the puzzling speckle tracking echocardiography/clinical severity dissociation between patients with takotsubo syndrome and anterior ST-elevation myocardial infarction".
    Int J Cardiol. 2025 Sep 17:133910. doi: 10.1016/j.ijcard.2025.133910.
    PubMed    


  127. BICCIRE FG, Di Pietro R, Tu S, Budassi S, et al
    Predictive value of coronary lesion functional assessment using an OCT computational algorithm in the CLIMA study.
    Int J Cardiol. 2025;435:133410.
    PubMed     Abstract available


  128. OCANA G, Michaud K, Magnin V, Van der Wal AC, et al
    Coronary CT angiography-derived pericoronary fat attenuation index: Post-mortem histopathological correlation in fatal plaques.
    Int J Cardiol. 2025;435:133388.
    PubMed     Abstract available


  129. LINGAMSETTY SSP, Doma M, Kritya M, Thyagaturu H, et al
    Mechanical outcomes of coronary stenting guided by intravascular ultrasound versus optical coherence tomography: A systematic review and meta-analysis with trial sequential analysis of randomized trials.
    Int J Cardiol. 2025;435:133387.
    PubMed     Abstract available


  130. KELLER K, Schmitt VH, Hobohm L, Espinola-Klein C, et al
    Risk factors for myocardial infarction in patients with peripheral artery disease.
    Int J Cardiol. 2025 Sep 11:133898. doi: 10.1016/j.ijcard.2025.133898.
    PubMed     Abstract available


  131. LENG L, Liu X, Song C, Ran X, et al
    Intra-aortic balloon pump implantation in early-stage cardiogenic shock reduces 30-day mortality in patients with ventricular septal defect following myocardial infarction.
    Int J Cardiol. 2025 Sep 10:133895. doi: 10.1016/j.ijcard.2025.133895.
    PubMed     Abstract available


  132. LOPEZ RI, Morello M, Golino M, Hogwood AC, et al
    Interleukin-1 blockade in patients with ST-segment elevation myocardial infarction with and without history of coronary artery disease.
    Int J Cardiol. 2025 Sep 10:133888. doi: 10.1016/j.ijcard.2025.133888.
    PubMed     Abstract available


  133. ALFONSO F, Salamanca J, Rivero F
    Cardiogenic shock after acute myocardial infarction: The importance of adherence to management recommendations.
    Int J Cardiol. 2025;442:133860.
    PubMed    


  134. MADIAS JE
    On the puzzling speckle tracking echocardiography/clinical severity dissociation between patients with takotsubo syndrome and anterior ST-elevation myocardial infarction.
    Int J Cardiol. 2025 Sep 6:133878. doi: 10.1016/j.ijcard.2025.133878.
    PubMed    


  135. MANEGAONKAR SM, Effat MA, van de Hoef TP, Lee JM, et al
    Delineating coronary epicardial stenosis status from microvascular dysfunction using pressure-drop coefficient from multicenter ILIAS registry.
    Int J Cardiol. 2025;442:133864.
    PubMed     Abstract available


  136. ZHANG X, Jin Q, Li C, Yang J, et al
    Prognostic value of angiography-derived microcirculatory resistance in patients undergoing rotational atherectomy- a multi-center study.
    Int J Cardiol. 2025;434:133322.
    PubMed     Abstract available


    August 2025
  137. NILSEN DWT, Leon De La Fuente R, Gallo P, Naesgaard P, et al
    Reply to: Could interleukin-1 receptor antagonist be a reliable predictor of prognosis in acute myocardial infarction?
    Int J Cardiol. 2025 Aug 22:133812. doi: 10.1016/j.ijcard.2025.133812.
    PubMed    


  138. TIAN J, Wang Y
    Could interleukin-1 receptor antagonist be a reliable predictor of prognosis in acute myocardial infarction?
    Int J Cardiol. 2025 Aug 21:133811. doi: 10.1016/j.ijcard.2025.133811.
    PubMed    


  139. POLLER A, Bech-Hanssen O, Redfors B
    Reply to comment on "Global and segmental longitudinal and radial strain in Takotsubo versus ST-elevation myocardial infarction" by Poller et al.
    Int J Cardiol. 2025 Aug 20:133801. doi: 10.1016/j.ijcard.2025.133801.
    PubMed    


  140. NILSEN DWT, Leon De La Fuente R, Gallo P, Naesgaard P, et al
    Reply to: Letter to the editor: High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients.
    Int J Cardiol. 2025 Aug 19:133807. doi: 10.1016/j.ijcard.2025.133807.
    PubMed    


  141. LONN A, Carroll SJ, Niyonsenga T, Bauman A, et al
    Reply to comment on associations between change in moderate-to-vigorous physical activity and sedentary behaviour with risk of recurrent cardiovascular events among individuals with coronary heart disease: A prospective cohort study.
    Int J Cardiol. 2025 Aug 17:133800. doi: 10.1016/j.ijcard.2025.133800.
    PubMed    


  142. DWT N, Leon De La Fuente R, Gallo P, Naesgaard P, et al
    Reply to: Reinterpreting interleukin-1 receptor antagonist elevation in acute myocardial infarction.
    Int J Cardiol. 2025 Aug 17:133797. doi: 10.1016/j.ijcard.2025.133797.
    PubMed    


  143. LATERRA G, Barbanti M, Rosato S, Biancari F, et al
    Incidence of cardiac ischemic events after transcatheter aortic valve replacement: Results from the OBSERVANT studies.
    Int J Cardiol. 2025 Aug 12:133779. doi: 10.1016/j.ijcard.2025.133779.
    PubMed     Abstract available


  144. CHEN J, Yang K
    Comment on "Global and segmental longitudinal and radial strain in Takotsubo versus ST-elevation myocardial infarction" by Poller et al.
    Int J Cardiol. 2025 Aug 9:133760. doi: 10.1016/j.ijcard.2025.133760.
    PubMed    


  145. ZHU B, Xu Y
    Letter to "Impact of frailty assessment on outcomes in critical acute myocardial infarction: Insights from the hospital frailty risk measure (HFRM)".
    Int J Cardiol. 2025 Aug 8:133724. doi: 10.1016/j.ijcard.2025.133724.
    PubMed    


  146. ZOU JH, Wang HW, Long JZ, Yang XN, et al
    Unveiling the diagnostic and causal role of hyperlipidemia- and lipophagy-associated genes PLAUR, IVNS1ABP, and QKI in acute myocardial infarction.
    Int J Cardiol. 2025 Aug 7:133635. doi: 10.1016/j.ijcard.2025.133635.
    PubMed     Abstract available


  147. BIRTOLO LI, Lattanzio A, Di Pietro G
    Editorial of "Real world comparative effectiveness of angiotensin-neprilysin inhibition versus angiotensin receptor blockers in acute myocardial infarction" to International Journal of Cardiology.
    Int J Cardiol. 2025;440:133705.
    PubMed    


  148. XIE P, Wang H, Xiao J, Xu F, et al
    Generative AI-powered explainable prediction model: Enhancing early in-hospital mortality alert for patients with acute myocardial infarction.
    Int J Cardiol. 2025 Aug 5:133649. doi: 10.1016/j.ijcard.2025.133649.
    PubMed     Abstract available


  149. ZHAO J, Peng Y
    Letter to the editor: High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients are associated with increased rates of all-cause mortality and cardiac death at five years follow-up.
    Int J Cardiol. 2025 Aug 5:133719. doi: 10.1016/j.ijcard.2025.133719.
    PubMed    


  150. MORONI F, Golino M, Abbate A
    Unopposed inflammation and long-term outcomes after acute myocardial infarction.
    Int J Cardiol. 2025 Aug 4:133710. doi: 10.1016/j.ijcard.2025.133710.
    PubMed    


  151. YANG Y, Jiao X, Shi J
    Moderate-to-vigorous physical activity and sedentary behavior dynamics in coronary heart disease: modifiable targets or mere risk indicators?
    Int J Cardiol. 2025 Aug 2:133714. doi: 10.1016/j.ijcard.2025.133714.
    PubMed    


  152. ESMEL-VILOMARA R, Riaza L, Dolader P, Rodriguez-Santiago B, et al
    Infarct-like myocarditis in adolescents: Exploring genetic insights from diagnosis through follow-up.
    Int J Cardiol. 2025;432:133255.
    PubMed     Abstract available


    July 2025
  153. LI L, Tang S, Li Y, Zhou X, et al
    Reply to letter to the editor: Real-world comparative effectiveness of angiotensin-neprilysin inhibition versus angiotensin receptor blockers in acute myocardial infarction.
    Int J Cardiol. 2025;440:133693.
    PubMed    


  154. LIU Y, Li C, Wang L, Hao X, et al
    Report on the adherence to key management strategies and mortality rates in patients with acute myocardial infarction-related cardiogenic shock: Finding from the improving Care for Cardiovascular Disease in China-acute coronary syndrome project.
    Int J Cardiol. 2025 Jul 26:133666. doi: 10.1016/j.ijcard.2025.133666.
    PubMed     Abstract available


  155. DWT N, Leon De La Fuente R, Gallo P, Naesgaard P, et al
    High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients are associated with increased rates of all-cause mortality and cardiac death at five years follow-up.
    Int J Cardiol. 2025;439:133674.
    PubMed     Abstract available


  156. POLLER A, Jha S, Molander L, Espinosa AS, et al
    Global and segmental longitudinal and radial strain in Takotsubo versus ST-elevation myocardial infarction.
    Int J Cardiol. 2025;439:133668.
    PubMed     Abstract available


  157. YAO Y, Wu Y
    Letter to the editor: Real-world comparative effectiveness of angiotensin-neprilysin inhibition versus angiotensin receptor blockers in acute myocardial infarction.
    Int J Cardiol. 2025 Jul 21:133657. doi: 10.1016/j.ijcard.2025.133657.
    PubMed    


  158. SUN R, Li L
    The comment on "Associations between changes in moderate-to-vigorous physical activity and sedentary behaviour with recurrent cardiovascular events among individuals with coronary heart disease".
    Int J Cardiol. 2025 Jul 16:133631. doi: 10.1016/j.ijcard.2025.133631.
    PubMed    


  159. SU X, Qiu M, Liu H, Xu K, et al
    Prolonged dual antiplatelet therapy strategy in acute coronary syndrome patients post-standard therapy and adverse event-free: An analysis based on OPT-CAD risk score stratification.
    Int J Cardiol. 2025;439:133636.
    PubMed     Abstract available


  160. DE GREGORIO C, Granata L, Raspanti D, Giannino F, et al
    Cephalosporin triggered Kounis syndrome: Pathophysiological and clinical insights.
    Int J Cardiol. 2025;431:133249.
    PubMed     Abstract available


  161. LAMMENS J, Motoc A, Tanaka K, Belsack D, et al
    Favorable impact of FFR(CT) on myocardial revascularization outcomes: Results from an observational real-world registry.
    Int J Cardiol. 2025;431:133245.
    PubMed     Abstract available


  162. KUHN L, Akin I, Steinke P, Abumayyaleh M, et al
    Obesity is associated with impaired long-term prognosis in patients undergoing coronary angiography: Results from a large-scaled single centre registry.
    Int J Cardiol. 2025;431:133252.
    PubMed     Abstract available


  163. YAMAMOTO K, Saito Y, Tateishi K, Kato K, et al
    Relation between previously implanted coronary stents and vasospasm: Patient- and vessel-level analysis.
    Int J Cardiol. 2025;431:133248.
    PubMed     Abstract available


  164. LI Z, Huang S, Li H, Liu Q, et al
    PERK's novel agonist protects against myocardial ischemia-reperfusion injury by modulating ER-mitochondria contacts and phosphatidic acid transport.
    Int J Cardiol. 2025;431:133222.
    PubMed     Abstract available


  165. LIU T, Fan Z, Li Y, Xiao B, et al
    Combination treatment of SGLT2i and GLP-1RA associated with improved cardiovascular outcomes in type 2 diabetes patients with acute coronary syndrome: A propensity score-matched cohort study.
    Int J Cardiol. 2025;431:133229.
    PubMed     Abstract available


  166. WANG J, Li C, Zhang M, Zhou J, et al
    The performance of angiography-derived index of microcirculatory resistance for ischemia in angina with non-obstructive coronary artery disease: Validated by wire-based IMR and SPECT-MPI.
    Int J Cardiol. 2025;431:133236.
    PubMed     Abstract available


  167. ZHU Y, Wang X, Su S, Qiao Z, et al
    Interpretable hybrid-ensemble acute myocardial infarction diagnosis with clinical transparency.
    Int J Cardiol. 2025 Jul 5:133598. doi: 10.1016/j.ijcard.2025.133598.
    PubMed     Abstract available


  168. TANG S, Li L, Chen H, Geru A, et al
    Real-world comparative effectiveness of angiotensin-neprilysin inhibition versus angiotensin receptor blockers in acute myocardial infarction.
    Int J Cardiol. 2025 Jul 3:133543. doi: 10.1016/j.ijcard.2025.133543.
    PubMed     Abstract available


  169. YINHUA L, Hu Y, Ziyue Z, Zhou J, et al
    Systemic coagulation-inflammation index in the prediction of ISR in patients undergoing drug-eluting stents implant: A retrospective study based on multiple machine learning methods.
    Int J Cardiol. 2025;430:133215.
    PubMed     Abstract available


  170. NAMBA HF, Boerhout CKM, Damman P, Kunadian V, et al
    Invasive coronary function testing in clinical practice: Implementing the 2024 ESC guidelines on chronic coronary syndromes.
    Int J Cardiol. 2025;430:133176.
    PubMed     Abstract available


  171. FAN C, Yan H, Lei K, Li D, et al
    Association of fasting blood glucose with in-hospital mortality in acute coronary syndrome patients with different glycemic statuses: Findings from the CCC-ACS project.
    Int J Cardiol. 2025;430:133184.
    PubMed     Abstract available


  172. TSAI TY, Revaiah PC, Aldujeli A, Miyashita K, et al
    Cumulative plaque burden analysis for phenotyping epicardial coronary artery disease.
    Int J Cardiol. 2025;430:133173.
    PubMed     Abstract available


    June 2025
  173. PEIRO OM, Bardaji A, Carrasquer A, Cediel G, et al
    Reply to "Growth differentiation factor 15 and empagliflozin in acute myocardial infarction: Correspondence".
    Int J Cardiol. 2025;438:133531.
    PubMed    


  174. CHEN L, Ge L, Abdu FA, Du X, et al
    Prognostic value of CMR-derived extracellular volume in myocardial infarction with non-obstructive coronary arteries.
    Int J Cardiol. 2025;437:133528.
    PubMed     Abstract available


  175. ZHANG X, Jin Q, Xue Q
    Reply to: Interplay between angiography-derived microcirculatory resistance and periprocedural myocardial infarction following rotational atherectomy.
    Int J Cardiol. 2025;437:133490.
    PubMed    


  176. GUARNIERI G, Pozzi FE, Conte E, Righetto M, et al
    Extreme endurance training and coronary artery disease: A systematic review and a meta-analysis.
    Int J Cardiol. 2025;429:133172.
    PubMed     Abstract available


  177. BERRY C, Camici PG, Crea F, George M, et al
    Clinical standards in angina and non-obstructive coronary arteries: A clinician and patient consensus statement.
    Int J Cardiol. 2025;429:133162.
    PubMed     Abstract available


  178. LONN A, Carroll SJ, Niyonsenga T, Bauman A, et al
    Associations between change in moderate-to-vigorous physical activity and sedentary behaviour with risk of recurrent cardiovascular events among individuals with coronary heart disease: A prospective cohort study.
    Int J Cardiol. 2025;437:133513.
    PubMed     Abstract available


  179. SMARZ K, Tysarowski M
    Response to comment on "Low chronotropic response in post-myocardial infarction exercise test predicts worse prognosis in patients with preserved or mildly reduced left ventricular ejection fraction".
    Int J Cardiol. 2025;437:133484.
    PubMed    


  180. BIASIN M, Cordioli N, Armani I, Guerrieri L, et al
    Lipid profiles in ST-elevation myocardial infarction with and without diabetes: the gap between prescription and targets.
    Int J Cardiol. 2025;437:133474.
    PubMed     Abstract available


  181. HAN J, Wang Z, Chen T, Liu S, et al
    Artificial intelligence driven plaque characterization and functional assessment from CCTA using OCT-based automation: A prospective study.
    Int J Cardiol. 2025;428:133140.
    PubMed     Abstract available


  182. KUNA C, Bradaric C, Koch T, Presch A, et al
    Age-related ten-year outcomes after percutaneous coronary intervention of in-stent restenosis.
    Int J Cardiol. 2025;428:133109.
    PubMed     Abstract available


    May 2025
  183. GRIFFITH GJ
    Chronotropic incompetence and the importance of cardiopulmonary exercise testing following myocardial infarction.
    Int J Cardiol. 2025 May 31:133445. doi: 10.1016/j.ijcard.2025.133445.
    PubMed    


  184. CARLSON PE, Schwager S, Feldewerd K, Schmidt S, et al
    The use of supersaturated oxygen therapy in patients with late-presentation anterior ST-segment elevation myocardial infarction.
    Int J Cardiol. 2025;436:133429.
    PubMed    


  185. AHMAD MH, Bilal M, Ibrahim M, Iman H, et al
    Letter to editor on low chronotropic response in post-myocardial infarction exercise test predicts worse prognosis in patients with preserved or mildly reduced left ventricular ejection fraction.
    Int J Cardiol. 2025 May 27:133432. doi: 10.1016/j.ijcard.2025.133432.
    PubMed    


  186. GIALLAURIA F, Vigorito C
    Editorial to "Impact of Frailty Assessment on Outcomes in Critical Acute Myocardial Infarction: Insights from the Hospital Frailty Risk Measure (HFRM)", Wu et al., Int J Cardiol. 2025 Apr 22:133294. doi: 10.1016/j.ijcard.2025.133294. Epub ahead of pri
    Int J Cardiol. 2025;435:133418.
    PubMed    


  187. FERRI N
    "SES", "SESS", or "SVESS" approaches for patients with myocardial infarction.
    Int J Cardiol. 2025;435:133412.
    PubMed    


  188. LAMELAS P, Sa MP, Izcovich A, Bottaro F, et al
    Percutaneous or surgical revascularization in patients with severe left main coronary artery disease in Latin America: A GRADE clinical practice guideline.
    Int J Cardiol. 2025 May 20:133401. doi: 10.1016/j.ijcard.2025.133401.
    PubMed     Abstract available


  189. FROYSA V, Berg GJ, Singsaas E, Eftestol T, et al
    Texture-based probability mapping for automatic assessment of myocardial injury in late gadolinium enhancement images after revascularized STEMI.
    Int J Cardiol. 2025;427:133107.
    PubMed     Abstract available


  190. DZIEWIERZ A
    Interplay between angiography-derived microcirculatory resistance and periprocedural myocardial infarction following rotational atherectomy.
    Int J Cardiol. 2025;435:133395.
    PubMed    


  191. HAIDER A, Imran A
    Comment on "Low chronotropic response in post-myocardial infarction exercise test predicts worse prognosis in patients with preserved or mildly reduced left ventricular ejection fraction".
    Int J Cardiol. 2025;435:133394.
    PubMed    


  192. ZARRAR M
    Growth Differentiation Factor 15 and Empagliflozin in acute myocardial infarction: Correspondence.
    Int J Cardiol. 2025 May 11:133365. doi: 10.1016/j.ijcard.2025.133365.
    PubMed    


  193. PETERS EJ, Henriques JPS
    Response to the Letter to the Editor on "Sex disparities in myocardial infarction related cardiogenic shock".
    Int J Cardiol. 2025 May 3:133311. doi: 10.1016/j.ijcard.2025.133311.
    PubMed    


  194. GUPTA R, Yadav O, Gupta N, Yadav A, et al
    Re: Use of supersaturated oxygen therapy in patients with late-presentation anterior ST-segment elevation myocardial infarction.
    Int J Cardiol. 2025;434:133355.
    PubMed    


  195. STEITIEH D, Beale R, Katznelson E, Feldman E, et al
    Trends in mechanical circulatory support utilization, left ventricular assist device implantation and transplant during cardiogenic shock hospitalizations, after the new heart allocation policy.
    Int J Cardiol. 2025;426:133054.
    PubMed     Abstract available


    April 2025
  196. PATTI G, Cumitini L, Bosco M, Marengo A, et al
    Impact of a personalized, strike early and strong approach on non-HDL-cholesterol levels and outcome in patients with acute myocardial infarction.
    Int J Cardiol. 2025 Apr 29:133327. doi: 10.1016/j.ijcard.2025.133327.
    PubMed     Abstract available


  197. SMARZ K, Tysarowski M, Ziolo J, Zaborska B, et al
    Low chronotropic response in post-myocardial infarction exercise test predicts worse prognosis in patients with preserved or mildly reduced left ventricular ejection fraction.
    Int J Cardiol. 2025;433:133320.
    PubMed     Abstract available


  198. WU S, Xu W, Hao B, Lin Z, et al
    Impact of frailty assessment on outcomes in critical acute myocardial infarction: Insights from the hospital frailty risk measure (HFRM).
    Int J Cardiol. 2025 Apr 22:133294. doi: 10.1016/j.ijcard.2025.133294.
    PubMed     Abstract available


  199. ABUSNINA W, Chaturvedi A, Chitturi KR, Lupu L, et al
    Gender disparities in cangrelor usage for the treatment of patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Int J Cardiol. 2025 Apr 12:133280. doi: 10.1016/j.ijcard.2025.133280.
    PubMed     Abstract available


  200. RAZAVI SR, Szun T, Zaremba AC, Cheung S, et al
    Predicting prolonged length of in-hospital stay in patients with non-ST elevation myocardial infarction (NSTEMI) using artificial intelligence.
    Int J Cardiol. 2025;432:133267.
    PubMed     Abstract available


  201. CARLSON PE, Schwager S, Feldewerd K, Schmidt S, et al
    The use of supersaturated oxygen therapy in patients with late-presentation anterior ST-segment elevation myocardial infarction.
    Int J Cardiol. 2025 Apr 8:133256. doi: 10.1016/j.ijcard.2025.133256.
    PubMed     Abstract available


  202. CILIBERTI G, Fortuni F, Santucci A, Timi A, et al
    Temporal trends of characteristics and management of patients with suspected MINOCA.
    Int J Cardiol. 2025;424:133039.
    PubMed     Abstract available


    March 2025
  203. HASAN M, Chola MH
    Comment on"Sex disparities in myocardial infarction related cardiogenic shock".
    Int J Cardiol. 2025;430:133209.
    PubMed    


  204. YANG X, Wu H, Liu D, Zhou G, et al
    Dynamic glycemic monitoring and systemic inflammation assessment: New insights into plaque characteristics in acute myocardial infarction.
    Int J Cardiol. 2025;430:133189.
    PubMed    


  205. OLIVERI F, van Oort MJH, Phagu AAS, Al Amri I, et al
    Intravascular lithotripsy in calcified left main coronary artery: Procedural success and 1-year clinical outcomes.
    Int J Cardiol. 2025;423:132996.
    PubMed     Abstract available


  206. PEIRO OM, Bardaji A, Carrasquer A, Cediel G, et al
    Growth differentiation factor 15: A biomarker to guide empagliflozin treatment in acute myocardial infarction?
    Int J Cardiol. 2025;429:133167.
    PubMed     Abstract available


  207. BILQUEES A, Saleem D, Aamir M
    Constructive feedback on the link between depression and acute myocardial infarction: A response to recent findings.
    Int J Cardiol. 2025;429:133156.
    PubMed    


  208. SAITO Y, Kobayashi Y
    Endeavor of exploring mechanisms of myocardial infarction in patients with no standard modifiable cardiovascular risk factors.
    Int J Cardiol. 2025;429:133155.
    PubMed    


  209. ROULE V, Singh M, Trimaille A, Delmas C, et al
    Prevalence of recreational drug use in myocardial infarction patients without standard modifiable risk factors: Insights from a multicenter prospective cohort study.
    Int J Cardiol. 2025 Mar 10:133146. doi: 10.1016/j.ijcard.2025.133146.
    PubMed     Abstract available


  210. SIRAW BB, Isha S, Mehadi AY, Tafesse YT, et al
    In-hospital outcomes of cardiogenic shock patients: A propensity score-matched nationwide comparative analysis between intra-aortic balloon pump and percutaneous ventricular assist devices.
    Int J Cardiol. 2025 Mar 3:133093. doi: 10.1016/j.ijcard.2025.133093.
    PubMed     Abstract available


  211. GALANTE D, Vicere A, Marrone A, Verardi FM, et al
    Fractional flow reserve (FFR) and index of microcirculatory resistance (IMR) relationship in patients with chronic or stabilized acute coronary syndromes.
    Int J Cardiol. 2025;422:132978.
    PubMed     Abstract available


  212. ZHANG M, Chen Q, Cheng K, Zhang W, et al
    Long non-coding RNA XR008038 promotes the myocardial ischemia/reperfusion injury development through increasing the expressions of galectin-3.
    Int J Cardiol. 2025;422:132955.
    PubMed     Abstract available


  213. XU J, Luo D, Lei Y, Hu Z, et al
    Correlation between abnormal microvascular perfusion and quantitative flow ratio after primary PCI in patients with STEMI.
    Int J Cardiol. 2025;422:132949.
    PubMed     Abstract available


  214. MANDURINO-MIRIZZI A, Munafo AR, Rizzo F, Raone L, et al
    Comparison of different guidance strategies to percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
    Int J Cardiol. 2025;422:132936.
    PubMed     Abstract available


    February 2025
  215. YI L, Quan W, Zhang M, Zhu T, et al
    Corrigendum to "Potential of(68)Ga-FAPI-04 PET/MR to predict worsening renal function after acute ST-elevation myocardial infarction" [International journal of cardiology vol. 414 (2024): 132425].
    Int J Cardiol. 2025;426:133086.
    PubMed    


  216. NISHI T, Saito Y, Tateishi K, Kobayashi Y, et al
    Safety and clinical implications of coronary spasm provocation testing in patients presenting with myocardial infarction with no overt culprit lesion.
    Int J Cardiol. 2025 Feb 20:133066. doi: 10.1016/j.ijcard.2025.133066.
    PubMed     Abstract available


  217. RICKEN KWLM, Lipsic E
    Reply to: Left atrial strain: A newly emerging prognostic marker for ST-elevation myocardial infarction.
    Int J Cardiol. 2025 Feb 18:133071. doi: 10.1016/j.ijcard.2025.133071.
    PubMed    


  218. YANG Y, Yan Y, Zhou Z, Zhang J, et al
    Accurate prediction of bleeding risk after coronary artery bypass grafting with dual antiplatelet therapy: A machine learning model vs. the PRECISE-DAPT score.
    Int J Cardiol. 2025;421:132925.
    PubMed     Abstract available


  219. PETERSON BE, Bhatt DL, Ballantyne CM, de Lemos JA, et al
    Inadequate Intensification of LDL-cholesterol lowering therapy after coronary revascularization: Insights from the GOULD registry.
    Int J Cardiol. 2025;421:132916.
    PubMed     Abstract available


  220. DENG C, Liu Z, Zhao R, Shi B, et al
    Intravascular imaging and functional assessment for coronary in-stent restenosis: Current status and future directions.
    Int J Cardiol. 2025;421:132918.
    PubMed     Abstract available


  221. OZAKI R, Motoyama S, Ozaki Y, Sarai M, et al
    Impact of CT-angiography derived plaque characteristics on cardiac events in patients with a negative invasive fractional flow reserve.
    Int J Cardiol. 2025;421:132895.
    PubMed     Abstract available


  222. KUBICA J, Adamski P, Ostrowska M, Kubica A, et al
    Prolonged antithrombotic treatment after de-escalation of dual antiplatelet therapy in patients after acute coronary syndrome - which strategy should be applied? The ELECTRA-SIRIO 2 investigators standpoint.
    Int J Cardiol. 2025;421:132897.
    PubMed     Abstract available


  223. DEMIREL C, Hamzaraj K, Fangl J, Hemetsberger R, et al
    Association of ABO blood group with risk of coronary stent thrombosis.
    Int J Cardiol. 2025;421:132758.
    PubMed     Abstract available


  224. MAURINA M, Riche M, Oliva O, Zendjebil S, et al
    Decoding medina 0.0.1 bifurcation: Are all codes equal? Results from a multicentric registry.
    Int J Cardiol. 2025;421:132863.
    PubMed     Abstract available


  225. SHAIKH S, Hamza M, Neppala S, Singh S, et al
    Colchicine for secondary prevention in patients with acute coronary syndrome: A systematic review and meta-analysis.
    Int J Cardiol. 2025 Feb 7:133045. doi: 10.1016/j.ijcard.2025.133045.
    PubMed     Abstract available


  226. MICHELSEN HO, Henriksson P, Wallert J, Back M, et al
    Retraction notice to "Organizational and patient-level predictors for attaining key risk factor targets in cardiac rehabilitation after myocardial infarction: The Perfect-CR study?" [International journal of Cardiology 371C (2022) 40-48].
    Int J Cardiol. 2025;420:132876.
    PubMed    


  227. KRAVCHENKO D, Vecsey-Nagy M, Varga-Szemes A, Hagar MT, et al
    Intra-individual radiomic analysis of pericoronary adipose tissue: Photon-counting detector vs energy-integrating detector CT angiography.
    Int J Cardiol. 2025;420:132749.
    PubMed     Abstract available


    January 2025
  228. MO SF, Zeng QP, Yang L
    Left atrial strain: A newly emerging prognostic marker for ST-elevation myocardial infarction.
    Int J Cardiol. 2025 Jan 31:133034. doi: 10.1016/j.ijcard.2025.133034.
    PubMed    


  229. DE SIO V, Gragnano F, Capolongo A, Guarnaccia N, et al
    Eligibility for and practical implications of Semaglutide in overweight and obese patients with acute coronary syndrome.
    Int J Cardiol. 2025;423:133028.
    PubMed     Abstract available


  230. WANG L, Wu H, Wu C, Shu L, et al
    A deep-learning system integrating electrocardiograms and laboratory indicators for diagnosing acute aortic dissection and acute myocardial infarction.
    Int J Cardiol. 2025 Jan 27:133008. doi: 10.1016/j.ijcard.2025.133008.
    PubMed     Abstract available


  231. SAITO T, Watanabe A, Aikawa T, Kapur NK, et al
    Comparison of temporary mechanical circulatory support devices for patients with cardiogenic shock after acute myocardial infarction: A network meta-analysis of randomized controlled trials.
    Int J Cardiol. 2025 Jan 25:132997. doi: 10.1016/j.ijcard.2025.132997.
    PubMed     Abstract available


  232. CHEN Y, Fang C, Zhao J, Jiang S, et al
    Glycemic control and coronary plaque characteristics in patients with acute myocardial infarction.
    Int J Cardiol. 2025;423:132988.
    PubMed     Abstract available


  233. KWOK CS, Borovac JA, Will M, Schwarz K, et al
    Hospitalizations during the 30-day period preceding the admission for the acute ST-elevation myocardial infarction: Insights from the Nationwide Readmission Database (NRD).
    Int J Cardiol. 2025 Jan 16:132991. doi: 10.1016/j.ijcard.2025.132991.
    PubMed     Abstract available


  234. BERNTORP K, Mohammad MA, Koul S, Yndigegn T, et al
    Deferral of left main coronary artery revascularization via IVUS or coronary physiology - Long-term outcomes from the SWEDEHEART registry.
    Int J Cardiol. 2025;419:132726.
    PubMed     Abstract available


  235. GIGANTE B, Chen Q, Bjorkbacka H, Bjornson E, et al
    Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis.
    Int J Cardiol. 2025;419:132698.
    PubMed     Abstract available


  236. SCHAUFELE T, Nobre Menezes M, Schulte Steinberg B, Hubert A, et al
    Effects of radial artery spasm prophylaxis on intracoronary vasomotor responses during acetylcholine spasm provocation testing.
    Int J Cardiol. 2025;419:132703.
    PubMed     Abstract available


  237. JENSEN RV, Jensen JM, Iraqi N, Grove EL, et al
    Coronary CT angiography instead of invasive angiography before TAVI: Feasibility and outcomes.
    Int J Cardiol. 2025;419:132694.
    PubMed     Abstract available


  238. URIBARRI A, Vazirani R, Delia MA, Tomasino M, et al
    Impact of mechanical circulatory support on outcomes in Takotsubo syndrome complicated by cardiogenic shock: Insights from the RETAKO registry.
    Int J Cardiol. 2025;419:132681.
    PubMed     Abstract available


  239. HE P, Chen H, Yang J, Gao L, et al
    The efficacy of an intracoronary cocktail administration in preventing no-reflow during excimer laser coronary angioplasty in patients with in-stent restenosis: A pilot study. (ELCA- cocktail study).
    Int J Cardiol. 2025;419:132666.
    PubMed     Abstract available


  240. MOLEDINA SM, Weight N, Cole A, Rashid M, et al
    The impact of specialist cardiology inpatient care on the long-term outcomes of non-ST-segment elevation myocardial infarction (NSTEMI): A nationwide cohort study.
    Int J Cardiol. 2025 Jan 15:132990. doi: 10.1016/j.ijcard.2025.132990.
    PubMed     Abstract available


  241. BAUER D, Spanyi SB, Neuberg M, Kocka V, et al
    Myocardial infarction in multivessel disease: Does presence of chronic total occlusion make a difference?
    Int J Cardiol. 2025 Jan 12:132984. doi: 10.1016/j.ijcard.2025.132984.
    PubMed     Abstract available


  242. KESTI H, Mattila K, Jaakkola S, Lehto J, et al
    Impact of high bleeding risk and associated risk factors on major adverse cardiovascular or cerebrovascular events in primary percutaneous coronary intervention treated ST-elevation myocardial infarction.
    Int J Cardiol. 2025 Jan 11:132986. doi: 10.1016/j.ijcard.2025.132986.
    PubMed     Abstract available


  243. HAKIM D, Ahmed M, Coskun AU, Maynard C, et al
    Spatial patterns of high-risk biomechanical metrics in plaques with abnormal vs. normal physiological flow indices.
    Int J Cardiol. 2025;418:132651.
    PubMed     Abstract available


  244. DE JONG EAM, Namba HF, Boerhout CKM, Feenstra RGT, et al
    Assessment of coronary endothelial dysfunction using contemporary coronary function testing.
    Int J Cardiol. 2025;418:132640.
    PubMed     Abstract available


  245. NAMBA HF, Boerhout CKM, de Jong EAM, van de Hoef TP, et al
    Aortic versus distal pressure for derivation of hyperaemic microvascular resistance: From the ILIAS registry.
    Int J Cardiol. 2025;418:132632.
    PubMed     Abstract available


  246. WOXHOLT S, Ueland T, Aukrust P, Anstensrud AK, et al
    Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI.
    Int J Cardiol. 2025;418:132613.
    PubMed     Abstract available


  247. CAHUAPAZA-GUTIERREZ NL, Calderon-Hernandez CC, Chambergo-Michilot D, De Arruda-Chaves E, et al
    Clinical characteristics, management, diagnostic findings, and various etiologies of patients with Kounis syndrome. A systematic review.
    Int J Cardiol. 2025;418:132606.
    PubMed     Abstract available


  248. MAHENDIRAN T, Thanou D, Senouf O, Jamaa Y, et al
    AngioPy Segmentation: An open-source, user-guided deep learning tool for coronary artery segmentation.
    Int J Cardiol. 2025;418:132598.
    PubMed     Abstract available


  249. GOYAL A, Tariq MD, Shahnoor S, Saeed H, et al
    Short- and long-term outcomes of antegrade versus retrograde approaches in patients undergoing percutaneous coronary intervention for chronic total occlusion: A meta-analysis.
    Int J Cardiol. 2025;418:132590.
    PubMed     Abstract available


    December 2024
  250. STANISLAWSKI R, Aboul-Hassan SS, Pieszko K, Awad AK, et al
    Long-term outcomes of minimally invasive direct coronary artery bypass vs second generation drug eluting stent for management of isolated left anterior descending artery disease.
    Int J Cardiol. 2024;422:132935.
    PubMed     Abstract available


  251. FATH AR, Elgendy IY
    Steps towards closing the sex-related disparities in acute myocardial infarction-related cardiogenic shock.
    Int J Cardiol. 2024 Dec 24:132928. doi: 10.1016/j.ijcard.2024.132928.
    PubMed    


  252. RICKEN KWLM, Lenselink C, Venema CS, van der Horst ICC, et al
    Left atrial strain predicts long-term heart failure outcomes after ST-elevation myocardial infarction.
    Int J Cardiol. 2024 Dec 22:132931. doi: 10.1016/j.ijcard.2024.132931.
    PubMed     Abstract available


  253. KATAMINE M, Minami Y, Nagata T, Asakura K, et al
    High-sensitivity C-reactive protein, plaque vulnerability and adverse events in patients with stable coronary disease: An optical coherence tomography study.
    Int J Cardiol. 2024;421:132924.
    PubMed     Abstract available


  254. TINDALE A, Elghazaly H, Baker C, Panoulas V, et al
    External validation of the BE-ALIVE score for predicting 30-day mortality in patients presenting with acute coronary syndromes.
    Int J Cardiol. 2024;417:132560.
    PubMed     Abstract available


  255. LOUTATI R, Bruoha S, Taha L, Karmi M, et al
    Association between peak troponin level and prognosis among patients admitted to intensive cardiovascular care unit.
    Int J Cardiol. 2024;417:132556.
    PubMed     Abstract available


  256. CHO S, Cho H, Min H, Lee JG, et al
    Clinical impact of deep learning-derived intravascular ultrasound characteristics in patients with deferred coronary artery.
    Int J Cardiol. 2024;417:132543.
    PubMed     Abstract available


  257. IMPROTA R, Di Pietro G, Piccialuti A, De Filippo O, et al
    Invasive and conservative management of elderly patients presenting with acute coronary syndrome: A meta-analysis of randomized controlled trials and adjusted observational studies.
    Int J Cardiol. 2024;417:132523.
    PubMed     Abstract available


  258. WATANABE A, Miyamoto Y, Ueyama H, Gotanda H, et al
    The use of pulmonary artery catheter and clinical outcomes in older adults with cardiogenic shock.
    Int J Cardiol. 2024;417:132509.
    PubMed     Abstract available


  259. SUNDQVIST MO, Svensson P, Soderberg S, Bergdahl IA, et al
    Seroprevalence of Helicobacter pylori and incident myocardial infarction - A population-based Swedish nested case-control study.
    Int J Cardiol. 2024 Dec 15:132917. doi: 10.1016/j.ijcard.2024.132917.
    PubMed     Abstract available


  260. SIA CH, Ho AFW
    Cardiogenic shock in the setting of acute myocardial infarction: Still a difficult entity to treat.
    Int J Cardiol. 2024;421:132886.
    PubMed    


  261. QIAN L, Zhang S, Lin C, Lin J, et al
    Depression exacerbates myocardial ischemia-reperfusion injury in mice via CNR2 gene and MIF-AMPK signaling pathway.
    Int J Cardiol. 2024;416:132505.
    PubMed     Abstract available


  262. TEIXEIRA L, Ferreira ROM, Navalha DDP, Pasqualotto E, et al
    Intravascular imaging-guided vs. angiography-guided percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials in high-risk patients and complex coronary anatomies.
    Int J Cardiol. 2024;416:132510.
    PubMed     Abstract available


  263. LIU Y, Huang M, Dai W
    Letter to the editor: Drug-coated balloon angioplasty versus drug-eluting stent implantation in ACS patients with different angiographic patterns of in-stent restenosis.
    Int J Cardiol. 2024;416:132501.
    PubMed    


  264. MONARES-ZEPEDA E, Barrera-Hoffmann C, Cueto-Robledo G, Navarro-Vergara DI, et al
    Mechanical power in cardiogenic shock.
    Int J Cardiol. 2024;416:132499.
    PubMed    


  265. WU Y, Lin Y, Liu B, Ma J, et al
    Shexiang Tongxin dropping pill ameliorates microvascular obstruction via downregulating ALOX12 after myocardial ischemia-reperfusion.
    Int J Cardiol. 2024;416:132481.
    PubMed     Abstract available


  266. ZHANG W, Zhang W, Deng Y, Gu N, et al
    Non-target lesion progression: Unveiling critical predictors and outcomes in patients with in-stent restenosis.
    Int J Cardiol. 2024;416:132451.
    PubMed     Abstract available


    November 2024
  267. FEZZI S, Pesarini G, Flaim M, Ding D, et al
    Influence of physiological patterns of coronary disease on fractional flow reserve and instantaneous wave-free ratio changes in patients undergoing TAVI.
    Int J Cardiol. 2024 Nov 25:132761. doi: 10.1016/j.ijcard.2024.132761.
    PubMed     Abstract available


  268. ALEKSOVA A, Fluca AL, Janjusevic M, Padoan L, et al
    Differences between MINOCA and type 2 myocardial infarction: An ITALIAN observational study.
    Int J Cardiol. 2024 Nov 24:132745. doi: 10.1016/j.ijcard.2024.132745.
    PubMed     Abstract available


  269. ZHU Q, Li X
    Reply to "Can IGFBP5 levels predict major adverse cardiac events in hyperglycemic AMI patients?".
    Int J Cardiol. 2024;415:132471.
    PubMed    


  270. VINK CEM, de Jong EAM, Woudstra J, Molenaar M, et al
    The role of myocardial blood volume in the pathophysiology of angina with non-obstructed coronary arteries: The MICORDIS study.
    Int J Cardiol. 2024;415:132479.
    PubMed     Abstract available


  271. IWANCZYK S, Lazar FL, Onea HL, Pesenti N, et al
    Sirolimus-coated balloon versus drug-eluting stent for complex coronary lesions. A propensity matched comparison.
    Int J Cardiol. 2024;415:132436.
    PubMed     Abstract available


  272. LECHNER I, Reindl M, Metzler B, Reinstadler SJ, et al
    Temporal trends in ACS outcomes: Balancing technological advances with patient complexity.
    Int J Cardiol. 2024;415:132442.
    PubMed    


  273. XIE H, Qiu M, Li X, Xiao Y, et al
    Drug-coated balloon angioplasty versus drug-eluting stent implantation in ACS patients with different angiographic patterns of in-stent restenosis.
    Int J Cardiol. 2024;415:132450.
    PubMed     Abstract available


  274. KINI AS, Garcia H, Springer B, Vengrenyuk A, et al
    A mobile application for STEMI care optimization: Pilot implementation project report.
    Int J Cardiol. 2024;415:132447.
    PubMed     Abstract available


  275. LIANG ES, Liu X
    Slamf8: A potential therapeutic target for cardiac ischemia/reperfusion injury.
    Int J Cardiol. 2024;415:132446.
    PubMed    


  276. ONG P, Seitz A
    Precision medicine in the treatment of STEMI patients - it's time for coronary physiology!
    Int J Cardiol. 2024;415:132429.
    PubMed    


  277. DI VITO L, Di Giusto F, Mazzotta S, Scalone G, et al
    Management of vulnerable patient phenotypes and acute coronary syndrome mechanisms.
    Int J Cardiol. 2024;415:132365.
    PubMed     Abstract available


  278. PETERS EJ, Ten Berg S, Bogerd M, Engstrom AE, et al
    Sex disparities in myocardial infarction related cardiogenic shock.
    Int J Cardiol. 2024;420:132730.
    PubMed     Abstract available


  279. HOOKANA I, Junttila J
    Reply to the letter "Age-related trends of ischemic sudden cardiac death in women".
    Int J Cardiol. 2024;414:132439.
    PubMed    


  280. SHARMA R, Aggarwal G, Kumar A, Thakur AK, et al
    Effect of loss-of-function CYP2C19 variants on clinical outcomes in coronary artery disease patients treated with clopidogrel: A systematic meta-analysis approach.
    Int J Cardiol. 2024;414:132418.
    PubMed     Abstract available


  281. XU W
    Ultrasonic flow ratio to diagnosis the functional significance of coronary stenosis undergoing percutaneous coronary intervention.
    Int J Cardiol. 2024;414:132427.
    PubMed    


  282. KOOP Y, Nathoe H, Bots M, Grobbee DE, et al
    Octopus follow-up: 20 year prognosis in patients randomized to on-pump CABG, off-pump CABG or PCI.
    Int J Cardiol. 2024;414:132426.
    PubMed     Abstract available


  283. NAKAMURA R, Shiono Y, Honda K, Kunimoto H, et al
    Risk factors for unsuccessful restoration of coronary flow reserve after coronary bypass surgery.
    Int J Cardiol. 2024;414:132419.
    PubMed     Abstract available


  284. SAMI SZ
    Letter to the Editor: The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndrome.
    Int J Cardiol. 2024;414:132406.
    PubMed    


  285. EL-NAGGAR HM, Soliman MG, Demitry SR, Ahmed TAN, et al
    Vitamin-K antagonist versus dual antiplatelet therapy in management of isolated and non-obstructive atherosclerotic coronary artery ectasia.
    Int J Cardiol. 2024;414:132412.
    PubMed     Abstract available


  286. REGIS SC, Del Castillo-Rix D, Duque JC, Colombo R, et al
    Evaluating the incidence and risk factors for developing acute tubular necrosis after percutaneous coronary intervention in the management of coronary artery dissection.
    Int J Cardiol. 2024;414:132403.
    PubMed     Abstract available


  287. JIANG Y, Wei ZY, Wu YJ, Dou KF, et al
    The impacts of percutaneous coronary intervention to treat chronic total occlusion of right coronary artery on the 5-year prognosis: A single-centered retrospective study.
    Int J Cardiol. 2024;414:132384.
    PubMed     Abstract available


    October 2024
  288. WEIGHT N, Singh S, Moledina S, Mamas MA, et al
    The processes of care and long-term mortality of acute myocardial infarction with cardiogenic shock survivors: A nationwide cohort study.
    Int J Cardiol. 2024 Oct 21:132669. doi: 10.1016/j.ijcard.2024.132669.
    PubMed     Abstract available


  289. GRECO A, Scalia L, Laudani C, Spagnolo M, et al
    Downstream cangrelor versus upstream ticagrelor in patients with ST-segment elevation myocardial infarction: A propensity score-matched analysis.
    Int J Cardiol. 2024;418:132660.
    PubMed     Abstract available


  290. FANG Y, Huang S, Zhang H, Yu M, et al
    The association between fibrinogen-to-albumin ratio and adverse prognosis in patients with myocardial infarction with non-obstructive coronary arteries.
    Int J Cardiol. 2024 Oct 17:132665. doi: 10.1016/j.ijcard.2024.132665.
    PubMed     Abstract available


  291. BAN T, Chang Y, Yu R
    Can IGFBP5 levels predict major adverse cardiac events in hyperglycemic AMI patients?
    Int J Cardiol. 2024;413:132407.
    PubMed    


  292. LORCA R, Aparicio A, Gutierrez L, Alvarez-Velasco R, et al
    PCSK9 gene variations in the clinical setting of premature cardiovascular disease: A critical appraisal.
    Int J Cardiol. 2024;413:132402.
    PubMed     Abstract available


  293. BIANCHINI E, Basile M, Bianchini F, Zito A, et al
    Multivessel revascularization in non-ST segment elevation acute coronary syndromes: A systematic review and meta-analysis of 182,798 patients.
    Int J Cardiol. 2024;413:132392.
    PubMed     Abstract available


  294. MICHAUD K, van der Wal AC
    Age and sex disparities in myocardial ischemia-related deaths at autopsy.
    Int J Cardiol. 2024;413:132362.
    PubMed    


  295. IWUAGWU M, Olapoju O, Abolaji M
    Age- related trends of ischemic sudden cardiac death in women.
    Int J Cardiol. 2024;413:132349.
    PubMed    


  296. CHUNTA A, Miller RJH
    Uncovering STEMI patient phenotypes using unsupervised machine learning.
    Int J Cardiol. 2024;413:132346.
    PubMed    


  297. OLMO RF, Cortez G, Toro MM, Sandin M, et al
    A machine learning algorithm for the identification elevated Lp(a) in patients with, or high-risk of having, coronary heart disease.
    Int J Cardiol. 2024 Oct 2:132612. doi: 10.1016/j.ijcard.2024.132612.
    PubMed     Abstract available


  298. DENG C, Liu Z, Li C, Xu G, et al
    Predictive models for cholesterol crystals and plaque vulnerability in acute myocardial infarction: Insights from an optical coherence tomography study.
    Int J Cardiol. 2024 Oct 2:132610. doi: 10.1016/j.ijcard.2024.132610.
    PubMed     Abstract available


  299. GUGLIELMO M, Fusini L, Baessato F, Baggiano A, et al
    PROGnostic RolE of strain measurements in stress cardiac MRI in predicting major adverse cardiac events.
    Int J Cardiol. 2024;412:132337.
    PubMed     Abstract available


  300. AYAYO SA, Kontopantelis E, Martin GP, Zghebi SS, et al
    Temporal trends of in-hospital mortality and its determinants following percutaneous coronary intervention in patients with acute coronary syndrome in England and Wales: A population-based study between 2006 and 2021.
    Int J Cardiol. 2024;412:132334.
    PubMed     Abstract available


  301. WU Z, Liu T, Yang Z, Li Y, et al
    Exploring the path of inflammatory markers as clinical prognostic biomarkers in older NSTEACS patients.
    Int J Cardiol. 2024;412:132309.
    PubMed    


  302. WANG YP, Xu XD, Xu X, Zhu L, et al
    Aucubin protects against myocardial ischemia-reperfusion injury via activation of the AKT/STAT3 pathway.
    Int J Cardiol. 2024;412:132311.
    PubMed    


  303. ZHANG ZJ
    The need to account for concurrent thrombus aspiration when investigating the adverse impact of post-dilation during percutaneous coronary intervention.
    Int J Cardiol. 2024;412:132296.
    PubMed    


  304. KUMAR M, Kumar N, Upreti P, Zaka Haider M, et al
    Drug-eluting stent vs. Balloon angioplasty in patients with in-stent restenosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Int J Cardiol. 2024;412:132269.
    PubMed     Abstract available


    September 2024
  305. DE LUCA L, Maggioni AP, Cavallini C, Leonardi S, et al
    Clinical profile and management of patients with acute myocardial infarction admitted to cardiac care units: The EYESHOT-2 registry.
    Int J Cardiol. 2024;418:132601.
    PubMed     Abstract available


  306. ZHANG Q, Zhu T, Mingqiang AO, Chen J, et al
    Correlation between serum levels of circ_0001879 and circ_0004104, coronary microcirculation disorders and prognosis after percutaneous coronary intervention (PCI) in patients with stable coronary heart disease.
    Int J Cardiol. 2024 Sep 18:132559. doi: 10.1016/j.ijcard.2024.132559.
    PubMed     Abstract available


  307. PROVENZALE G, Barbieri L, Tumminello G, Carugo S, et al
    Exercise response in post-acute coronary syndrome patients survived to COVID-19 infection.
    Int J Cardiol. 2024;411:132285.
    PubMed     Abstract available


  308. TILLER C, Reindl M, Lechner I, Reinstadler SJ, et al
    Circulating progenitor cells: A promising biomarker for coronary collateral formation in CTO?
    Int J Cardiol. 2024;411:132267.
    PubMed    


  309. GADAGER BB, Tang LH, Doherty P, Svendsen ML, et al
    Are cardiac rehabilitation pathways influenced by diabetes: A cohort study.
    Int J Cardiol. 2024;411:132275.
    PubMed     Abstract available


  310. DI FRANCO A
    Navigating complexity among surgical myocardial revascularization strategies: Endoscopic coronary artery bypass gains support.
    Int J Cardiol. 2024;410:132240.
    PubMed    


  311. ABU ARAB T, Sedhom R, Gomaa Y, El Etriby A, et al
    Intracoronary adenosine compared with adrenaline and verapamil in the treatment of no-reflow phenomenon following primary PCI in STEMI patients.
    Int J Cardiol. 2024;410:132228.
    PubMed     Abstract available


  312. BAHARVAND F, Habibi Roudkenar M, Pourmohammadi-Bejarpasi Z, Najafi-Ghalehlou N, et al
    Safety and efficacy of platelet-derived mitochondrial transplantation in ischaemic heart disease.
    Int J Cardiol. 2024;410:132227.
    PubMed     Abstract available


  313. HOOKANA I, Eskuri MAE, Holmstrom L, Vahatalo J, et al
    Age-related trends of ischemic sudden cardiac death in women.
    Int J Cardiol. 2024;410:132238.
    PubMed    


  314. ABOAL J, Ramos R, Martin C, Loma-Osorio P, et al
    Evaluation of the ODISEA APP for improving a STEMI regional network.
    Int J Cardiol. 2024;410:132217.
    PubMed     Abstract available


  315. ABDELBASIT MS
    How often is emergency coronary artery bypass grafting required during chronic total occlusion coronary intervention?
    Int J Cardiol. 2024;410:132215.
    PubMed    


  316. TIERNEY M, Norman S, Al Ahmad J, Hansen T, et al
    A 10-year review of presentation, management and outcomes of STEMI in a high-volume regional tertiary Australian centre.
    Int J Cardiol. 2024;410:132224.
    PubMed     Abstract available


  317. REGIS SC, Del Castillo-Rix D, Colombo R
    Patterns of coronary artery disease trends in patients with nephrotic syndrome: A national inpatient study.
    Int J Cardiol. 2024;410:132200.
    PubMed     Abstract available


    August 2024
  318. YAN M, Fu H, Zhang X, Xu K, et al
    More attention needs to focus on the diabetic cardiomyopathy without coronary artery disease.
    Int J Cardiol. 2024;409:132194.
    PubMed    


  319. MENDEL B
    Gender differences in the diagnostic efficacy of coronary CTA: Overutilization of coronary CTA in pre- and perimenopausal females? An editorial comment.
    Int J Cardiol. 2024;409:132193.
    PubMed    


  320. GOLD DA, Sandesara PB, Jain V, Gold ME, et al
    N terminal pro-brain natriuretic peptide level and benefits of chronic total occlusion revascularization.
    Int J Cardiol. 2024;409:132196.
    PubMed     Abstract available


  321. HOSSEINI K, Behnoush AH, Khalaji A, Etemadi A, et al
    Machine learning prediction of one-year mortality after percutaneous coronary intervention in acute coronary syndrome patients.
    Int J Cardiol. 2024;409:132191.
    PubMed     Abstract available


  322. BRUNO F, De Filippo O, D'Ascenzo F
    Reply to "Sex disparities for clinical outcomes after percutaneous coronary intervention for acute coronary syndrome" by Sterpetti et al.
    Int J Cardiol. 2024;409:132186.
    PubMed    


  323. ROMANOV A, Nikitin N
    Epicardial adipose tissue for atrial arrhythmias prediction in coronary artery disease. Are we close to the gold marker?
    Int J Cardiol. 2024;409:132176.
    PubMed    


  324. FERNANDES-SILVA MM, Conti-Pelanda JD, Vosgerau LM, Cunha GSP, et al
    Temporal trends in the contribution of modifiable cardiovascular risk factors to cardiovascular and all-cause mortality in patients undergoing myocardial perfusion imaging in a large city in Brazil.
    Int J Cardiol. 2024;409:132178.
    PubMed     Abstract available


  325. FEUCHTNER GM, Lacaita PG, Barbieri F, Deeg J, et al
    Gender differences in the diagnostic efficacy of coronary CTA: Overutilization of coronary CTA in pre- and perimenopausal females?
    Int J Cardiol. 2024;409:132181.
    PubMed     Abstract available


  326. SAMPON F, Ter Woorst J, Dekker L, Akca F, et al
    Thoracoscopic-assisted, minimally invasive versus off-pump bypass grafting for single vessel coronary artery disease - A propensity matched analysis.
    Int J Cardiol. 2024;409:132175.
    PubMed     Abstract available


  327. FRACASSI F, Animati FM, Cappannoli L, Burzotta F, et al
    Thin-cap fibroatheroma: the trigger of acute coronary syndromes. Pathophysiological and prognostic importance of in-vivo detection.
    Int J Cardiol. 2024;409:132157.
    PubMed    


  328. SI X, Hou C, Wang H, Yan W, et al
    Comparison of six Z-score formulas based on echocardiography for coronary artery lesions in Kawasaki disease.
    Int J Cardiol. 2024;409:132102.
    PubMed     Abstract available


  329. YI L, Quan W, Zhang M, Zhu T, et al
    Potential of (68)Ga-FAPI-04 PET/MR to predict worsening renal function after acute ST-elevation myocardial infarction.
    Int J Cardiol. 2024 Aug 2:132425. doi: 10.1016/j.ijcard.2024.132425.
    PubMed     Abstract available


  330. GHOBRIAL M, Bawamia B, Cartlidge T, Purcell I, et al
    The role of gender in resting full-cycle ratio (RFR) guided coronary revascularization.
    Int J Cardiol. 2024;408:132159.
    PubMed     Abstract available


  331. HONGQUAN L, Nina C, Xia Y, Lujiang Z, et al
    BECN1 regulates FADD/RIPK1/Caspase-8 complex formation via RIPK1 ubiquitination by downregulating OTUD1 in MI/R induced myocyte apoptosis.
    Int J Cardiol. 2024;408:132158.
    PubMed     Abstract available


  332. LANDI A, Heg D, Frigoli E, Routledge H, et al
    Negative selection bias for women inclusion in a clinical trial.
    Int J Cardiol. 2024;408:132138.
    PubMed     Abstract available


  333. ALGHAMMASS M, Arora S
    Navigating complex waters: Revascularization strategies and outcomes in post-CABG patients.
    Int J Cardiol. 2024;408:132120.
    PubMed    


    July 2024
  334. DE FERRARI T, Pistelli L, Franzino M, Molinero AE, et al
    MI2AMI-CS: A meta-analysis comparing Impella and IABP outcomes in acute myocardial infarction-related cardiogenic shock.
    Int J Cardiol. 2024 Jul 31:132411. doi: 10.1016/j.ijcard.2024.132411.
    PubMed     Abstract available


  335. TSENG CH
    Metformin-associated lactic acidosis and mortality in type 2 diabetes patients hospitalized with heart failure and/or acute coronary syndrome: A neglected clinical scenario and the potential role of insulin.
    Int J Cardiol. 2024 Jul 30:132400. doi: 10.1016/j.ijcard.2024.132400.
    PubMed    


  336. LI YY, Chen HR, Yang Y, Pan YJ, et al
    Murine exosomal miR-30a aggravates cardiac function after acute myocardial infarction via regulating cell fate of cardiomyocytes and cardiac resident macrophages.
    Int J Cardiol. 2024 Jul 27:132395. doi: 10.1016/j.ijcard.2024.132395.
    PubMed     Abstract available


  337. NAJAFI-GHALEHLOU N, Baharvand F, Pourmohammadi-Bejarpasi Z, Roushandeh AM, et al
    The importance of platelet-derived mitochondrial transplantation in ischemic heart disease: A clinical study.
    Int J Cardiol. 2024;413:132408.
    PubMed    


  338. DENG L, Xia Q, Zhang L
    Commentary on "Automated control of Impella maintains optimal left ventricular unloading during periods of unstable hemodynamics and prevents myocardial damage in acute myocardial infarction".
    Int J Cardiol. 2024;413:132383.
    PubMed    


  339. D'ERRIGO P, De Luca L, Rosato S, Giordani B, et al
    Prognostic role of coronary angiography and revascularization in patients firstly admitted for heart failure in Italy.
    Int J Cardiol. 2024 Jul 23:132369. doi: 10.1016/j.ijcard.2024.132369.
    PubMed     Abstract available


  340. GOLD DA, Sandesara PB, Kindya B, Gold ME, et al
    Circulating Progenitor Cells and Coronary Collaterals in Chronic Total Occlusion.
    Int J Cardiol. 2024;407:132104.
    PubMed     Abstract available


  341. CANDREVA A, Buongiorno AL, Matter MA, Rizzini ML, et al
    Impact of endothelial shear stress on coronary atherosclerotic plaque progression and composition: A meta-analysis and systematic review.
    Int J Cardiol. 2024;407:132061.
    PubMed     Abstract available


  342. GROEN RA, Barbero FL, Fischer SE, van Dijkman PRM, et al
    Coronary artery calcium assessment on non-gated chest CT to optimize pre-operative cardiac screening in liver transplantation.
    Int J Cardiol. 2024;407:132015.
    PubMed     Abstract available


  343. SMITH SW, Meyers HP
    ST Elevation is a poor surrogate for acute coronary occlusion. Let's Replace STEMI with Occlusion MI (OMI)!!
    Int J Cardiol. 2024;407:131980.
    PubMed    


  344. KOH SJQ, Jiang Y, Lau YH, Yip WLJ, et al
    Optimal door-to-balloon time for primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Int J Cardiol. 2024;413:132345.
    PubMed     Abstract available


  345. ZHANG L, Liu Z, Zeng J, Wu M, et al
    Long-term effects of air quality on hospital readmission for heart failure in patients with acute myocardial infarction.
    Int J Cardiol. 2024 Jul 6:132344. doi: 10.1016/j.ijcard.2024.132344.
    PubMed     Abstract available


  346. LIU S, Qian F, Lu Q, Deng Y, et al
    Association of life's essential 8 with risk of recurrent cardiovascular events among patients with coronary heart disease.
    Int J Cardiol. 2024;412:132318.
    PubMed     Abstract available


  347. BASEM M, Bonnesen K, Schmidt M
    Potential of the Danish Comorbidity Index for Acute Myocardial Infarction to discriminate mortality in patients with infective endocarditis.
    Int J Cardiol. 2024 Jul 2:132328. doi: 10.1016/j.ijcard.2024.132328.
    PubMed     Abstract available


  348. SIGLE M, Faller W, Heurich D, Zdanyte M, et al
    Machine learning predicts emergency physician specialties from treatment strategies for patients suspected of myocardial infarction.
    Int J Cardiol. 2024 Jul 2:132332. doi: 10.1016/j.ijcard.2024.132332.
    PubMed     Abstract available


  349. FUJINO M, Aikawa H, Nakao K, Takagi K, et al
    Comparison of embolic risk in left ventricular thrombus between nonischemic and ischemic cardiomyopathy: A nationwide database analysis.
    Int J Cardiol. 2024 Jul 2:132329. doi: 10.1016/j.ijcard.2024.132329.
    PubMed     Abstract available


  350. LEE YJ, Park G, Lee SG, Cho YK, et al
    Predictive value of plaque characteristics for identification of lesions causing ischemia.
    Int J Cardiol. 2024;406:132097.
    PubMed     Abstract available


  351. AKSIT E, Kucuk U, Kirilmaz B
    The increasing importance of lipid lowering therapies as a part of the 'first medical contact' in patients with acute coronary syndrome.
    Int J Cardiol. 2024;406:132095.
    PubMed    


  352. GASECKA A, Blazejowska E, Pluta K, Gajewska M, et al
    Ticagrelor downregulates the expression of proatherogenic and proinflammatory miR125-b compared to clopidogrel: A randomized, controlled trial.
    Int J Cardiol. 2024;406:132073.
    PubMed     Abstract available


  353. MOMMERSTEEG PMC, Lodder P, Aarnoudse W, Magro M, et al
    Psychosocial distress and health status as risk factors for ten-year major adverse cardiac events and mortality in patients with non-obstructive coronary artery disease.
    Int J Cardiol. 2024;406:132062.
    PubMed     Abstract available


  354. TILLMANNS J, Weiglein JM, Neuser J, Fraccarollo D, et al
    Circulating soluble fibroblast activation protein (FAP) levels are independent of cardiac and extra-cardiac FAP expression determined by targeted molecular imaging in patients with myocardial FAP activation.
    Int J Cardiol. 2024;406:132044.
    PubMed     Abstract available


  355. REN Y, Chen L, Liu J, Wu Y, et al
    Correlation of epicardial adipose tissue and inflammatory indices in patients with STEMI and implications for atrial arrhythmias.
    Int J Cardiol. 2024;406:132016.
    PubMed     Abstract available


  356. CHADHA RM
    CT coronary angiography: Is it the new standard in coronary assessment for liver transplant candidates?
    Int J Cardiol. 2024;406:131999.
    PubMed    


  357. YAZDANPANAH M, Yazdanpanah N, Chardoli M, Dehghan A, et al
    Role of interleukin 6 signaling pathway in the anti-inflammatory effects of statins on coronary artery disease: Evidence from Mendelian randomization analysis.
    Int J Cardiol. 2024;406:131964.
    PubMed     Abstract available


    June 2024
  358. CORDERO A, Oterino A
    Individualization of prasugrel dose for patients with acute myocardial infarction.
    Int J Cardiol. 2024 Jun 29:132313. doi: 10.1016/j.ijcard.2024.132313.
    PubMed    


  359. KUBAT GB
    The importance of platelet-derived mitochondrial transplantation in ischemic heart disease: A clinical study.
    Int J Cardiol. 2024;412:132312.
    PubMed    


  360. LIU XH, Zhang L
    Role of anakinra in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2024 Jun 25:132297. doi: 10.1016/j.ijcard.2024.132297.
    PubMed    


  361. JIN Y, Shen L, Ye R, Zhou M, et al
    Development and validation of a novel score for predicting perioperative major adverse cardiovascular events in patients with stable coronary artery disease undergoing noncardiac surgery.
    Int J Cardiol. 2024;405:131982.
    PubMed     Abstract available


  362. BEERKENS FJ, Kucuk IT, van Veelen A, de Lind van Wijngaarden RAF, et al
    Native coronary artery or bypass graft percutaneous coronary intervention in patients after previous coronary artery bypass surgery: A large nationwide analysis from the Netherlands Heart Registration.
    Int J Cardiol. 2024;405:131974.
    PubMed     Abstract available


  363. LI C, Deng C, Shi B, Zhao R, et al
    Thin-cap fibroatheroma in acute coronary syndrome: Implication for intravascular imaging assessment.
    Int J Cardiol. 2024;405:131965.
    PubMed     Abstract available


  364. IN KIM Y, Roh JH, Kweon J, Kwon H, et al
    Artificial intelligence-based quantitative coronary angiography of major vessels using deep-learning.
    Int J Cardiol. 2024;405:131945.
    PubMed     Abstract available


  365. SCHINDLER TH, Sadhu J
    Moving towards PET determined coronary flow capacity in outcome prediction after coronary revascularization?
    Int J Cardiol. 2024;405:131921.
    PubMed    


  366. MUTLU D, Rempakos A, Alexandrou M, Al-Ogaili A, et al
    Emergency coronary artery bypass surgery after chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Int J Cardiol. 2024;405:131931.
    PubMed     Abstract available


  367. TOFTHOLM MH, Hojstrup S, Talleruphuus U, Marner L, et al
    82-rubidium positron emission tomography determined myocardial flow reserve and outcomes following cardiac revascularisation - A multicentre registry study.
    Int J Cardiol. 2024;405:131865.
    PubMed     Abstract available


  368. MATETIC A, Kyriacou T, Mamas MA
    Machine-learning clustering analysis identifies novel phenogroups in patients with ST-elevation acute myocardial infarction.
    Int J Cardiol. 2024 Jun 14:132272. doi: 10.1016/j.ijcard.2024.132272.
    PubMed     Abstract available


  369. ZHU Q, Cheang I, Guo Q, Lu X, et al
    Serum IGFBP5 as a predictor of major adverse cardiac events in patients with acute myocardial infarction.
    Int J Cardiol. 2024 Jun 14:132268. doi: 10.1016/j.ijcard.2024.132268.
    PubMed     Abstract available


  370. CHEN Y, Zhang N, Gao Y, Zhou Z, et al
    A coronary CT angiography-derived myocardial radiomics model for predicting adverse outcomes in chronic myocardial infarction.
    Int J Cardiol. 2024 Jun 14:132265. doi: 10.1016/j.ijcard.2024.132265.
    PubMed     Abstract available


  371. WANG L, Travieso A, van der Hoeven N, Lombardi M, et al
    Angiography-versus wire-based microvascular resistance index to detect coronary microvascular obstruction associated with ST-segment elevation myocardial infarction.
    Int J Cardiol. 2024 Jun 10:132256. doi: 10.1016/j.ijcard.2024.132256.
    PubMed     Abstract available


  372. BANJAR S, Alharbi S, Omer I, Al Zaid N, et al
    Effect of sodium-glucose co-transporter 2 inhibitors (SGLT2i) on N-terminal pro-B-type natriuretic peptide (NT-proBNP) level and structural changes following myocardial infarction: A systematic review and meta-analysis.
    Int J Cardiol. 2024;410:132239.
    PubMed     Abstract available


  373. NISHIKAWA T, Kamada K, Morita H, Matsushita H, et al
    Automated control of Impella maintains optimal left ventricular unloading during periods of unstable hemodynamics and prevents myocardial damage in acute myocardial infarction.
    Int J Cardiol. 2024;410:132244.
    PubMed     Abstract available


  374. MCCHORD J, Ong P
    Advancing precision medicine in INOCA research: The INOCA-IT registry.
    Int J Cardiol. 2024;404:131975.
    PubMed    


  375. SHIBA M, Kato T, Seko Y, Minamino-Muta E, et al
    Cobalt protoporphyrin promotes heme oxygenase 1 expression and ameliorates cardiac dysfunction in long-term fasting mice.
    Int J Cardiol. 2024;404:131972.
    PubMed     Abstract available


  376. STERPETTI AV, Gabriele R, Di Marzo L
    Sex disparities for clinical outcomes after percutaneous coronary intervention for acute coronary syndrome.
    Int J Cardiol. 2024;404:131937.
    PubMed    


  377. BACIGALUPI E, Pelliccia F, Zimarino M
    Diabetes mellitus and in-stent restenosis: A direct link or something more?
    Int J Cardiol. 2024;404:131922.
    PubMed    


  378. GOLINO M, Harding D, Del Buono MG, Fanti S, et al
    Innate and adaptive immunity in acute myocarditis.
    Int J Cardiol. 2024;404:131901.
    PubMed     Abstract available


    May 2024
  379. HONDA S, Lee S, Cho KH, Takegami M, et al
    Clinical outcomes of adjusted-dose versus standard-dose prasugrel in East Asian patients with acute myocardial infarction.
    Int J Cardiol. 2024 May 30:132197. doi: 10.1016/j.ijcard.2024.132197.
    PubMed     Abstract available


  380. SUN L, Xu C, Zhang Z, Tang L, et al
    Physical activity lowers all-cause and cardio-cerebrovascular mortality in adults with coronary heart disease.
    Int J Cardiol. 2024;410:132225.
    PubMed     Abstract available


  381. REA F
    Progress in cardiovascular mortality: Latest data on mortality from ischemic heart disease.
    Int J Cardiol. 2024;409:132192.
    PubMed    


  382. CHEN G, Westra J, Yang X, Zhang Y, et al
    A simple Angio-based coronary flow assessment of culprit vessels in primary percutaneous coronary intervention is associated with long-term prognosis after ST-segment-elevation myocardial infarction.
    Int J Cardiol. 2024 May 21:132199. doi: 10.1016/j.ijcard.2024.132199.
    PubMed     Abstract available


  383. WANG SR, Huang KC, Lin TT, Chuang SL, et al
    The effect of antiarrhythmic medications on the risk of cardiovascular outcomes in patients with atrial fibrillation and coronary artery disease.
    Int J Cardiol. 2024 May 21:132198. doi: 10.1016/j.ijcard.2024.132198.
    PubMed     Abstract available


  384. UKITA K, Egami Y, Yano M, Nishino M, et al
    Reply to "Evaluation on mortality predictors after emergent percutaneous coronary intervention in acute myocardial infarction with ventricular arrhythmias: Details not to be ignored?".
    Int J Cardiol. 2024;409:132187.
    PubMed    


  385. YAO L, Hao K, Liu T, Jiang J, et al
    The miR-26b/CTGF axis: A promising therapeutic mechanism for managing myocardial fibrosis post myocardial infarction.
    Int J Cardiol. 2024;409:132185.
    PubMed    


  386. DIRJAYANTO VJ, Martin-Ruiz C, Pompei G, Rubino F, et al
    The association of inflammatory biomarkers and long-term clinical outcomes in older adults with non-ST elevation acute coronary syndrome.
    Int J Cardiol. 2024;409:132177.
    PubMed     Abstract available


  387. SAMPAIO RODRIGUES T, Narendren A, Cailes B, Lim RP, et al
    Enhancing pre-transplant cardiac assessment: Validation and utility of the CAD-LT score with CCTA in liver transplant candidates.
    Int J Cardiol. 2024;403:131895.
    PubMed     Abstract available


  388. XU P, Cao Y, Zhang S, Liu X, et al
    The predictive value of serum Dickkopf-1, Dickkopf-3 level to coronary artery disease and acute coronary syndrome.
    Int J Cardiol. 2024;403:131887.
    PubMed     Abstract available


  389. DOUGHTY A, Keane G, Wadley AJ, Mahoney B, et al
    Plasma concentrations of thioredoxin, thioredoxin reductase and peroxiredoxin-4 can identify high risk patients and predict outcome in patients with acute coronary syndrome: A clinical observation.
    Int J Cardiol. 2024;403:131888.
    PubMed     Abstract available


  390. SAARINEN SL, Borregaard B, Ekholm O, Christensen AV, et al
    Self-reported mental and physical health is associated with not returning to work in patients with ischemic heart disease.
    Int J Cardiol. 2024 May 15:132180. doi: 10.1016/j.ijcard.2024.132180.
    PubMed     Abstract available


  391. LOPEZ-PALOP R, Carrillo P, Lozano I
    Transient new-onset atrial fibrillaation during acute coronary syndrome: Transient arrhythmia, transient risk?
    Int J Cardiol. 2024 May 14:132163. doi: 10.1016/j.ijcard.2024.132163.
    PubMed    


  392. DE ALENCAR NETO JN, Scheffer MK, Correia BP, Franchini KG, et al
    Systematic review and meta-analysis of diagnostic test accuracy of ST-segment elevation for acute coronary occlusion.
    Int J Cardiol. 2024;402:131889.
    PubMed     Abstract available


  393. OLSEN FJ, Smiseth OA, Biering-Sorensen T
    Improving post-MI risk stratification with pressure-strain loops: Work in progress.
    Int J Cardiol. 2024;402:131866.
    PubMed    


  394. DI VITO L, Di Giusto F, Grossi P
    Non-culprit plaque progression: What do we know?
    Int J Cardiol. 2024;402:131881.
    PubMed    


  395. GHIZZONI G, Leone AM, di Serafino L, Galante D, et al
    "The INOCA-IT: Rationale and design of a multicenter registry investigating ischemia in patients with non-obstructive coronary artery (INOCA) disease in Italy".
    Int J Cardiol. 2024;402:131859.
    PubMed     Abstract available


  396. AL-YAFEAI Z, Sondhi M, Vadlamudi K, Vyas R, et al
    Novel anti-psoriasis agent-associated cardiotoxicity, analysis of the FDA adverse event reporting system (FAERS).
    Int J Cardiol. 2024;402:131819.
    PubMed     Abstract available


    April 2024
  397. JHAND AS, Abusnina W, Tak HJ, Ahmed A, et al
    Impact of anemia on outcomes and resource utilization in patients with myocardial infarction: A national database analysis.
    Int J Cardiol. 2024 Apr 30:132111. doi: 10.1016/j.ijcard.2024.132111.
    PubMed     Abstract available


  398. MIURA H, Koseki M, Ide S, Asaumi Y, et al
    Stronger positive correlation of the left ventricular mass index and extracellular volume fraction with diastolic function in diabetic patients without myocardial infarction.
    Int J Cardiol. 2024 Apr 23:132099. doi: 10.1016/j.ijcard.2024.132099.
    PubMed     Abstract available


  399. AL A, Babayigit E, Gorenek B
    Evaluation on mortality predictors after emergent percutaneous coronary intervention in acute myocardial infarction with ventricular arrhythmias: Details not to be ignored?
    Int J Cardiol. 2024;406:132079.
    PubMed    


  400. GIRERD N
    The underappreciated value of resting heart rate in post-myocardial infarction follow-up.
    Int J Cardiol. 2024 Apr 19:132059. doi: 10.1016/j.ijcard.2024.132059.
    PubMed    


  401. ANDO G, Lombardo L, Alagna G, Micari A, et al
    Monotherapy with P2Y(12)-inhibitors after dual antiplatelet therapy: Filling gaps in evidence.
    Int J Cardiol. 2024;401:131893.
    PubMed     Abstract available


  402. BRUNO F, de Filippo O, Sardone A, Capranzano P, et al
    Long-term impact of intravascular ultrasound-guidance for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric study.
    Int J Cardiol. 2024;401:131861.
    PubMed     Abstract available


  403. HAN D, Hyun MC, Miller RJH, Gransar H, et al
    10-year experience of utilizing a stress-first SPECT myocardial perfusion imaging.
    Int J Cardiol. 2024;401:131863.
    PubMed     Abstract available


  404. TANNER R, Farhan S, Giustino G, Sartori S, et al
    Impact of diabetes mellitus on clinical outcomes after first episode in-stent restenosis PCI: Results from a large registry.
    Int J Cardiol. 2024;401:131856.
    PubMed     Abstract available


  405. XIA B, Lu Y, Liang J, Li F, et al
    Association of GAL-8 promoter methylation levels with coronary plaque inflammation.
    Int J Cardiol. 2024;401:131782.
    PubMed     Abstract available


  406. RIEHLE C, Sieweke JT, Udesen NLJ, Helgestad OKL, et al
    Circulating biomarkers of the CS4P and CLIP scores are not altered in a pig model of acute cardiogenic shock and additional short-term circulatory support.
    Int J Cardiol. 2024;401:131699.
    PubMed     Abstract available


  407. WOLF S, Schievano E, Amidei CB, Kucher N, et al
    Mortality trend of ischemic heart disease (2008-2022): A retrospective analysis of epidemiological data.
    Int J Cardiol. 2024 Apr 12:132042. doi: 10.1016/j.ijcard.2024.132042.
    PubMed     Abstract available


  408. YANG J, Zhao Y, Wang J, Ma L, et al
    Current status of emergency medical service use in ST-segment elevation myocardial infarction in China: Findings from China Acute Myocardial Infarction (CAMI) Registry.
    Int J Cardiol. 2024 Apr 11:132040. doi: 10.1016/j.ijcard.2024.132040.
    PubMed     Abstract available


  409. JONG CB, Lu TS, Chen JW
    Reply to comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
    Int J Cardiol. 2024 Apr 10:132031. doi: 10.1016/j.ijcard.2024.132031.
    PubMed    


  410. UELAND T, Butt N, Lekva T, Orn S, et al
    High dose statin treatment reduces circulating Dickkopf-1 following acute myocardial infarction.
    Int J Cardiol. 2024 Apr 9:132035. doi: 10.1016/j.ijcard.2024.132035.
    PubMed     Abstract available


  411. YILDIRIM M, Giannitsis E, Mueller-Hennessen M
    Reply to: Kavsak et al. The clinical chemistry score (CCS) achieves the highest efficacy when assessed with the 99% sensitivity benchmark for myocardial infarction.
    Int J Cardiol. 2024 Apr 6:132030. doi: 10.1016/j.ijcard.2024.132030.
    PubMed    


  412. PETERSEN JK, Butt JH, Yafasova A, Torp-Pedersen C, et al
    Prognosis and antithrombotic practice patterns in patients with recurrent and transient atrial fibrillation following acute coronary syndrome: A nationwide study.
    Int J Cardiol. 2024 Apr 6:132017. doi: 10.1016/j.ijcard.2024.132017.
    PubMed     Abstract available


    March 2024
  413. CHENG Y, Zhang Q
    Comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
    Int J Cardiol. 2024 Mar 26:131979. doi: 10.1016/j.ijcard.2024.131979.
    PubMed    


  414. PINGITORE A, Zhang C, Vassalle C, Ferragina P, et al
    Machine learning to identify a composite indicator to predict cardiac death in ischemic heart disease.
    Int J Cardiol. 2024 Mar 23:131981. doi: 10.1016/j.ijcard.2024.131981.
    PubMed     Abstract available


  415. MCCORD J
    Identification and definition of type 2 myocardial infarction: Where do we go from here?
    Int J Cardiol. 2024 Mar 7:131941. doi: 10.1016/j.ijcard.2024.131941.
    PubMed    


  416. VAN DEN BROEK WWA, Gimbel ME, Hermanides RS, Runnett C, et al
    The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndrome.
    Int J Cardiol. 2024 Mar 7:131940. doi: 10.1016/j.ijcard.2024.131940.
    PubMed     Abstract available


  417. GIACOBBE F, Giannino G, Annone U, Morena A, et al
    Impact of statin adherence and interruption within 6 months after ST-segment elevation myocardial infarction (STEMI): Results from the real-world regional registry FAST-STEMI.
    Int J Cardiol. 2024 Mar 2:131933. doi: 10.1016/j.ijcard.2024.131933.
    PubMed     Abstract available


    February 2024
  418. POVLSEN AL, Helgestad OKL, Josiassen J, Christensen S, et al
    Invasive mechanical ventilation in cardiogenic shock complicating acute myocardial infarction: A contemporary Danish cohort analysis.
    Int J Cardiol. 2024 Feb 27:131910. doi: 10.1016/j.ijcard.2024.131910.
    PubMed     Abstract available


  419. BOURG C, Lee KC, Donal E
    Understanding myocardial mechanics in primary mitral regurgitation: A contemporary approach.
    Int J Cardiol. 2024 Feb 17:131882. doi: 10.1016/j.ijcard.2024.131882.
    PubMed    


  420. BOERHOUT CKM, Vink CEM, Lee JM, de Waard GA, et al
    Impact of sex on the assessment of the microvascular resistance reserve.
    Int J Cardiol. 2024 Feb 3:131832. doi: 10.1016/j.ijcard.2024.131832.
    PubMed     Abstract available


    December 2023
  421. BUJAK K, Rinaldi R, Vidal-Cales P, Montone RA, et al
    Immediate versus staged complete revascularization in acute coronary syndrome: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2023;393:131397.
    PubMed     Abstract available


  422. LIU S, Wang P, Liu C, Jin M, et al
    Effect of PCSK9 antibodies on coronary plaque regression and stabilization derived from intravascular imaging in patients with coronary artery disease: A meta-analysis.
    Int J Cardiol. 2023;392:131330.
    PubMed     Abstract available


  423. LI F, Peng J, Lu Y, Zhou M, et al
    Blockade of CXCR4 promotes macrophage autophagy through the PI3K/AKT/mTOR pathway to alleviate coronary heart disease.
    Int J Cardiol. 2023;392:131303.
    PubMed     Abstract available


    November 2023
  424. WEIGHT N, Moledina S, Rashid M, Chew N, et al
    Temporal analysis of non-ST segment elevation-acute coronary syndrome (NSTEACS) outcomes in 'young' patients under the age of fifty: A nationwide cohort study.
    Int J Cardiol. 2023;391:131294.
    PubMed     Abstract available


  425. KASKI JC, Lluch N, Lopez-Sendon JL, Gorog DA, et al
    Changes in circulating ApoJ-Glyc levels in patients with suspected acute coronary syndrome: The EDICA trial.
    Int J Cardiol. 2023;391:131291.
    PubMed     Abstract available


  426. KUZEMCZAK M, Lipiecki J, Jeyalan V, Farhat H, et al
    Clinical outcomes of coronary intravascular lithotripsy in patients with stent failure (COIL registry).
    Int J Cardiol. 2023;391:131274.
    PubMed     Abstract available


  427. DE KONING MLY, Al Ali L, Bourgonje AR, Assa S, et al
    Associations of systemic oxidative stress with functional outcomes after ST-segment elevation myocardial infarction.
    Int J Cardiol. 2023;391:131214.
    PubMed     Abstract available


    October 2023
  428. YIN ZY, Fu T, He SM, Fu L, et al
    16alpha-OHE1, a novel oestrogen metabolite, attenuates dysfunction of left ventricle contractility via regulation of autophagy after myocardial ischemia and reperfusion.
    Int J Cardiol. 2023;388:131123.
    PubMed     Abstract available


    September 2023
  429. EMMERT-FEES KMF, Luhar S, O'Flaherty M, Kypridemos C, et al
    Forecasting the mortality burden of coronary heart disease and stroke in Germany: National trends and regional inequalities.
    Int J Cardiol. 2023 Sep 25:131359. doi: 10.1016/j.ijcard.2023.131359.
    PubMed     Abstract available


  430. FONDERICO C, Pergola V, Faccenda D, Salucci A, et al
    Impact of sacubitril/valsartan and gliflozins on cardiac resynchronization therapy response in ischemic and non-ischemic heart failure patients.
    Int J Cardiol. 2023 Sep 23:131391. doi: 10.1016/j.ijcard.2023.131391.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum